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Preface 
For everything there is a season, 
and a time for every matter under heaven: 
... a time to keep silence, 
and a time to speak... 
Ecclesiaste 3:1,7b 
Time has always been an important and intriguing phenomenon to me. Time is a major 
diagnostic and therapeutic tool in general practice where most health problems are self-
limiting. Confidentiality and trust in a patient-doctor relationship needs time to develop. 
Time is inevitable in building up families and generations, the highly important milieu 
for general practitioners. For continuity of care, especially relevant in chronic diseases, 
time is conditional. Chronic diseases as subject of my thesis fit very well in this field of 
interest 
This thesis is based on a project with research and developmental aspects which 
started in December 1986 - time flies. The research questions evolved during the course 
of the project While initially measurements of prevalences and validity of diagnoses 
had been planned, during the project comorbidity of chrome diseases emerged as a 
theme of increasing importance. Moreover, the extensive phase .of analytic and 
reporting activities, starting in June 1991, contributed, in my view, to a more balanced 
product. This thesis is a result of a process rather than of an activity, a snapshot in an 
ongoing way of thinking rather than a definite outcome. 
May this thesis contribute to a further improvement of the quality of general 
practitioners' work in their care of patients with chronic diseases. 
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1. Introduction 
... The inevitability of the growth of the 
elderly population is certain to have a 
profound influence on the health care 
industry in the coming decades... ' 
1.1. Demographical and epidemiological developments 
The human species has entered a new era in its demographic evolution: population 
aging. The proportion of the population surviving into older ages is at a level unprece-
dented in human history [1]. Consequently, the attention of health care providers and 
medical investigators shifted during the last decades from the length to the quality of 
life, especially in old age. This has been expressed in the well-chosen phrase "adding life 
to years, not years to life" [2]. From the epidemiological point of view The Netherlands, 
like most countries in Western Europe and Northern America, nowadays are in the 
fourth phase of the epidemiological transition [3] or the "age of delayed degenerative 
diseases" [4]: the lengthening of human life is reaching a limit, and - due to more 
accurate diagnostic and therapeutic tools - degenerative and chronic diseases are 
detected earlier in life. Lengthening of this lead time' and more sophisticated medical 
care lead to a longer lifetime with disease, which is referred to as decompression or 
expansion of morbidity. 
Health measures, aimed at compression of morbidity [5,6], include primary 
prevention of chronic diseases by the elimination of causal factors. Primary prevention 
is the field of biomedical sciences, epidemiology, and public health. Secondary preven-
tion is the early detection and effective initial treatment of diseases. Secondary 
prevention has a positive influence on the course of a chronic disease, even at older 
ages [2,7]. Tertiary prevention includes health care for patients with established chronic 
diseases and aims at compression of disabling lifetime. The impact of tertiary preven-
tion on quality of life has only recently been recognized as a field of interest [8]. 
Growing older implies a higher risk at chronic diseases and consequently a higher 
risk at comorbidity of chronic diseases as incidence rates of the most common chronic 
diseases are age-dependent or aging-related [9]. The expected increase of the propor-
tion of people of 65 and over from 12.5% in 1988 to more than 21% in the year 2050 
[10], will considerably change the morbidity pattern of the practice population of 
general practitioners (GPs) [11], especially with regard to chronic diseases. 
Olshansky SJ, Auk AB. The fourth stage of the epidemiologic transition: the age of 
delayed degenerative diseases. Milbank Q 1986;64:355-391. 
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1.2. Chronic diseases in general practice . 
Studies on chronic diseases in general practice may increase our insight into the 
management of chronic diseases in general practice, and anticipate these future 
changes. Chronic diseases in the general population have recently been studied in view 
of public health policy [12]. In other recent studies incidences and prevalences of 
chronic diseases in general practice and aspects of the care for the elderly have been 
reported [13,14]. An earlier study in The Netherlands focused on comorbidity of newly 
diagnosed diseases [IS]. In the United Kingdom chronic diseases in general practice 
received attention from the educational point of view [16,17]. 
1.3. Objective of this study 
The objective of this study was to gain insight into the prevalence of chronic 
diseases in general practice and into the care of patients with chronic diseases provided 
by GPs. This global objective was pursued in detail guided by the following questions: 
a. How can comorbidity be defined? 
b. What is the validity of diagnoses of chronic diseases in general practice? 
с What is the prevalence of comorbidity of chronic diseases? 
d. What is the influence of comorbidity of chronic diseases on GP consultation rates 
and on the incidences of intercurrent diseases? 
e. Does the actual care of GPs during the follow-up of patients with chronic diseases 
become more in agreement with consensus guidelines for optimal care in course of 
time? 
f. What is the effect of the implementation of guidelines for follow-up care on the 
disease status of patients with chronic diseases in general practice? 
The study reported in this thesis is a part of the Dutch National Survey of General 
Practice, which is aimed at gaining insight into the patterns of diseases presented in 
general practice and into the care provided by GPs [18]. This part of the survey focuses 
on chronic diseases with special attention to comorbidity and quality of care. 
Comorbidity of chronic diseases, the existence of more than one chronic disease in 
one patient, has not received much attention, until recently. Comorbidity is, however, a 
reality of the dairy practice of GPs who have to deal with all diseases of a patient 
The second major theme, the care for patients with chronic diseases, is studied from 
the viewpoint of the quality of care, which is one of the concepts in the research of 
health care of patients with chronic diseases [19]. Quality of GP care has been given 
increasing attention in The Netherlands, especially trough the development of 
'standards' initiated by the Dutch College of General Practitioners [20]. However, the 
development of measures for the quality of care, has received much less attention so 
far. 
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1.4. Chronic diseases 
Defining chronic diseases is not a simple matter. A diagnostic definition, such as the 
definition of the U.S. Commission on Chronic Illness [21], is widely used but this 
definition comprises a broad range of health problems. Limitation to those chronic 
diseases that are Usted in the Health Interview Survey [22] is a pragmatic approach, but 
is more appropriate for studies of the general population. The use of criteria for 
chronicity is another approach, some of which have been applied in recent studies 
[12,13,23,24]. The following criteria are commonly used: 
a. a minimum duration of the disease, varying from 3 to б months, or the frequency of 
recurrence of the disease; 
b. the severity of the disease, often determined by the degree of impairment or 
disability; 
с the demand for (professional) health care. 
During the preparation of our study we decided to determine the choice of chronic 
diseases by the following criteria: 
1. the nature of the disease (generally accepted as chronic); 
2. its relatively high prevalence in the general practice population; 
3. the fact that GPs usually carry the first responsibility for the care of these patients. 
This third criterion excluded cancer, which is mainly managed by specialists, although it 
is recognized that patients with malignant neoplasms often receive extensive care from 
GPs too. Also excluded were mild chronic psychiatric disorders with a high prevalence 
in the general practice population, that are responsible for a substantial part of the GP 
workload. Psychiatric disorders are difficult to define, and the type of delivered care 
depends largely on the personal preference of patient and doctor, and on the skills of 
the GP. Therefore, prevalence and management of psychiatric disorders can better be 
studied separately. Chronic neurological conditions, such as Parkinson's disease and 
multiple sclerosis, have also been left aside. The prevalence of these diseases is 
relatively low, and not the GP but the neurologist is mostly the first responsible for the 
care of these patients. 
These considerations led to the choice of the following five chronic somatic diseases 
for this study: 
hypertension (strictly speaking not a disease but a risk factor); 
chronic ischemic heart disease (angina pectoris, previous myocardial infarction); 
diabetes mellitus; 
chronic respiratory disease (asthma, chrome bronchitis, emphysema); 
osteoarthritis of hip and/or knee. 
1.5. Quality of care 
The concept of quality, a frequently used and misused term, is difficult to define 
[25]. For use in the health care field, the concept of quality is often made operational 
by listing the characteristics of care which are considered to be related to its quality, 
e.g. effectiveness of medical procedures, availability of care, respectful attitude of pro­
fessional caregivers [26]. The cyclic process of quality management comprises three 
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elements: quality measures (e.g. guidelines), quality assessment, and quality improve-
ment [27]. 
The formulation and implementation of guidelines that reflect qualitatively good 
care is essential in assessing and improving quality of care [28]. The availability of such 
guidelines makes it possible to compare actually delivered care (performance) with 
optimal care. Since 1989 standards for optimal care are being developed by the Dutch 
College of General Practitioners. The problems encountered in developing and in 
implementing guidelines for good care have recently been surveyed [29,30]. 
In assessing the quality of care three aspects of care are usually considered: 
structure, process, and outcome [31]. The theoretically ideal process of quality assess-
ment and quality improvement meets many obstacles on its way to realization. Recently 
it was concluded that a systematic evaluation of the impact and effect of guidelines on 
the quality of care in general practice is still lacking [29]. In this study the effect of the 
formulation of guidelines and their implementation within a peer review process on the 
process and outcome of care is evaluated. The method of peer review, which was 
chosen for this study, is one of the possible strategies in assessing and improving quality 
of care [27]. This method was considered feasible within the framework of this study in 
view of the number of participating GPs and in view of the available experience with 
this method [32,33]. 
1.6. General practice in The Netherlands 
The task of the general practitioner as adopted by the Dutch College of General 
Practitioners is to deliver continuous, integral, and personal care to individual patients 
and their families [34]. In The Netherlands all non-institutionalized inhabitants are 
registered in a general practice. Generally, members of one family have the same GP. 
Continuity of care over generations and over time is highly important The mean 
practice list size is about 2300 persons. About half of the GPs work individually, one 
third in a practice with two GPs, and the others in a group practice or health centre. In 
most practices one or more practice assistants are present. Their tasks vary from mere 
administrative work to performance of medical procedures under supervision, depend-
ing on their skills and the willingness of the GP. There are daily consultation hours at 
the office. Home visits are made upon request 
In regional groups GPs organize their educational activities, and the evening and 
weekend services. There is no free access to specialized care: referrals are to be made 
by the GP. GPs can use laboratory facilities, and imaging and other diagnostic services 
without having to refer patients to a specialist 
General practitioners in The Netherlands are in a favourable position to deliver 
continuous care in every respect The setting of general practice is well suited for the 
management of comorbidity of chrome diseases and the optimalization of the care of 
these patients. GPs can play a leading part in assuring the quality of life of patients with 
chronic diseases and comorbidity. These will be important challenges for the near 
future. 
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1.7. Outline of the thesis 
Chapter 2 contains a systematic analysis of the literature on comorbidity. This 
review especially focuses on the definition of comorbidity and on methodological 
aspects. In chapter 3 a study on the validity of diagnoses of chronic diseases is 
described. Validity is measured by the agreement of diagnostic procedures with 
diagnostic inclusion criteria. A prevalence study on the extent of comorbidity of five 
common chronic diseases in general practice is reported in chapter 4. Chapter 5 
describes the influence of comorbidity of chronic diseases on the number of GP con­
sultations and on the extent of intercurrent morbidity. The chapters 6 and 7 report on 
the effects of formulation and implementation of guidelines for optimal follow-up care 
of patients with chronic diseases. In chapter 6 the effect on GP performance is 
described, chapter 7 presents the effect on outcome measures in patients with chronic 
diseases. The thesis finishes with chapter 8 in which the research questions are 
answered, and the study is discussed in general. A summary in different languages 
concludes this thesis. 
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2. Comorbidity - definitions and methodological aspects 
. How can mediane, which is commonly supposed 
to be a science, be so different in countries 
whose peoples are so similar genetically? ...' 
Abstract - In studying the literature on comorbidity very diverse definitions and applications 
of this concept were found. This led to a systematic literature search to make an inventory 
of definitions of comorbidity, of the diseases that are considered in studies of comorbidity, 
and of the methodological aspects of comorbidity. A systematic search through MedLine 
since 1985 yielded 70 publications. Reviewing these publications showed that in 33 
publications an 'explicit definition of comorbidity was mentioned. Définitions depended 
upon the type of relation between diseases. Three categories were distinguished: co-existence 
of diseases without any reference category, presence of other diseases than an index disease, 
and à relationship (association, correlation) between diseases. A wide variety of diseases 
was considered in the context of comorbidity. Most publications agreed upon the chronic 
nature of the comorbid diseases (diabetes, cancer, heart diseases). Most publications 
reported cohort or cross-sectional studies. In the reviewed publications comorbidity was 
most frequently used as an independent variable in the study (28 publications), less 
frequently as a confounding or modifying variable (23 publications). Measures of 
comorbidity included multiple variables indicating the presence or absence of specific 
diseases separately, the number or sum of diseases, one variable (indicating the presence or 
absence of any comorbid disease), and comorbidity indexes. Five different indexes were 
traced Mortality or survival was the main outcome variable in 32 publications, in thirteen 
publications comorbidity was the main outcome variable. A classification of comorbidity is 
proposed, based on the relationship between diseases. It is concluded that for a better 
understanding of the role of comorbidity there is a need for an agreed definition, for explicit 
mentioning of the diseases considered and for standardization of measures of comorbidity. 
Payer L· Medicine and culture. New York: Penguin Books, 1988. 
Scheilevis FG, Velden J vd, Eijk JThM v, Lisdonk EH va\ Weel С v. Comorbidity 
definitions and methodological aspects [Submitted]. 
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2.1. Introduction 
In recent years comorbidity has been recognized as an issue of interest in clinical 
epidemiological literature. For practising physicians the existence of multiple diseases in 
a single patient is evident, especially for disciplines of geriatrics, of nursing home 
medicine, and of general practice where the focus is not on the management of one 
specific disease or disorder. In medical research comorbidity is often dealt with as a 
possible cause of heterogeneity: patients with comorbidity are therefore often excluded 
from clinical trials. Several authors emphasize the limited external validity of the results 
of trials in which patients with specific characteristics as comorbidity are excluded [1-4]. 
In the literature on comorbidity many different ways of defining and handling the 
concept of comorbidity were found. This led to a systematic search in literature with the 
following questions: 
* How is comorbidity defined and how can these definitions be classified? 
* Which diseases are considered in studying comorbidity? 
* How is comorbidity methodologically handled? 
The aim of this report is to clarify the differences in handling the phenomenon of 
comorbidity in order to contribute to greater uniformity. The use of standard definitions 
and uniform'measures for comorbidity may lead to better comparability of study results 
and consequently to a better understanding of the role of comorbidity. 
2.2. Methods 
* 
Selection procedure 
The material for this literature study was collected by a systematic search in 
MedLine (CD-ROM, Silver Platter), using 'comorbidity' as the only search criterium 
(present as an index key word, or appearing in the title or in the abstract) in publica-
tions between 1985 and 1991. This resulted in a number of 379 titles (Table 2.1). 
Table 2.1. Number of references resulting from MedLine search with key word comorbidity per 
publication year 
Year of publication Number of references (abs) 
1985 1 
1986 12 
1987 18 
1988 40 
1989 77 
1990 97 
1991 134 
Total 379 
16 
On this material a four-step selection procedure was carried out (Figure 2.1). 
Step 1 
Considering only the title of the publication and bibliographical specifications the 
next exclusion criteria were applied: 
a. language: other than English or Dutch; 
b. type of publication: case study, letter to the editor; 
с major emphasis on psychiatric morbidity (in the psychiatric literature the term 
comorbidity is often used for the combination of a major mental illness with 
substance abuse and addiction disorders). 
On the basis of these criteria 232 titles were excluded. 
Step 2 
Of the remaining 147 titles the abstract, generated by MedLine, was studied. 
Excluded were publications meeting one of the following criteria (in parentheses the 
number of publications meeting this criterium): 
a. comorbidity in relation to diseases of dental origin (N=3); 
b. comorbidity in relation to exogenous factors as exposure to physical agents (N=6); 
с comorbidity in relation to remuneration systems of health care (N=14); 
d. editorials and abstracts indicating a publication with emphasis on education or 
reflection (N=27); 
e. abstracts indicating that comorbidity is a minor point in the study (comorbidity is an 
exclusion criterium, comorbidity is only mentioned in the discussion section as a 
hypothetical explanatory variable, the term comorbidity does not appear in the 
abstract) (N=37). 
The main reason for excluding publications on dental diseases, on financial topics, and 
on exogenous factors was the primary interest in the aspect of medical care. In this way 
87 publications were excluded. 
Step3 
The remaining 60 publications were carefully studied. The publications were 
categorized on the basis of the type of population in which the study took place (in 
parentheses the number of publications): 
general population (N=9) [5-13]; 
outpatient clinic population (N=9) [14-22]; 
patients during and after hospitalization (N=33) [23-55]; 
patients treated in dialysis centres (N=8) [56-63]; 
autopsy studies (N=1) [64]. 
The last two categories of studies were excluded in this review. 
Step 4 
Any reference listed in the remaining 51 publications that seemed to be relevant in 
the context of this literature study, was studied and tested by the criteria mentioned in 
the first two selection steps. References to sources other than journal publications (e.g. 
reports, books) were not traced. This yielded another 16 eligible publications, three 
studies in the general population [65-67], three in a setting of an outpatient clinic [68-
70], and 10 studies in hospitalized patients [71-80]. Screening of the titles of the 
17 
references listed in these 16 additional publications did not produce new sources. On 
the contrary, the circle of references seemed to close. Finally, three publications 
published in 1991 were added from the personal archive of the first author [81-83], one 
of a study in the general population, and two in a general practice setting. Ibis resulted 
in a total of 70 publications that have been reviewed. 
Figure 2.1. Selection of publications for a review on comorbidity 
Number of 
Procedure publications 
MedLine search 1985-1991: publications 
with 'comorbidity1 as key word, 
or appearing in title or abstract 379 
1 Excluded on the basis of: 
language, type of publication, or 
psychiatric morbidity · 232 
Remaining 147 
2 Excluded on the basis of: subject 
(dental diseases, exogenous factors, 
financial issues), editorial or 
educational paper, or comorbidity as 
minor point · 87 
Remaining 60 
3 Excluded on the basis of setting 
(dialysis centre, autopsy) · 9 
Remaining 51 
4 Additional publications 
a. from references of included publications 16 
b. from personal archive + 3 
Number of selected publications 70 
Reviewing procedure 
All publications were screened for definitions of comorbidity. Only definitions explicitly 
mentioned in the publication are considered. It was decided not to use implicit 
definitions, formulated on the basis of the context in which the term comorbidity is 
used, as this may introduce observer bias. 
The diseases or disease categories that were included under the term comorbidity in 
each publication, and the sources from which information about diseases was abstracted 
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were listed. In the publications studied a wide range of disease classifications, from 
global to detailed, was found. The diagnostic terms were left intact, except that obvious 
synonyms like 'pulmonary' and 'respiratory' were grouped together. Different types of 
sources of information on diseases are distinguished: self-report (written or by oral 
interview), medical records (including hospital charts, hospital discharge forms, clinical 
records, death certificates), and medical examinations, specially carried out for the 
study. Special attention is given to information in the publications about the application 
of diagnostic criteria in defining comorbid diseases. 
The methodological aspects the publications were screened for are the design of the 
study, the place or function of comorbidity in the study design and the way comorbidity 
is transformed to one or more measures for analysis. The place of comorbidity in the 
studies is categorized in four categories: outcome variable, independent variable, 
confounding/modifying variable, and a rest category. Measures of comorbidity used as 
analysis variable are classified as follows: 
a. comorbidity present or absent (one dichotomous variable); 
b. number of diseases / sum of comorbid diseases (one continuous variable); 
с presence or absence of specific diseases or disease categories separately (multiple 
dichotomous variables); 
e. index of comorbidity, indicating diseases weighted for, mostly, their severity. 
The term comorbidity refers to a co-existing ailment, additional to a particular 
'index' disease [84]. As the operationalisation of comorbidity is strongly related to the 
index disease, which indicates the main characteristic of the study population or the 
main independent variable in the study, index diseases were taken into account in 
studying the methodological aspects. 
23. Results 
Definition of comorbidity 
In 33 of the 70 publications an explicit definition of comorbidity was mentioned (in 
one publication two subclasses of comorbidity were defined). In most definitions the 
relationship between diseases is the central item. Therefore, it is logical to classify these 
definitions on the basis of the type of relationship between diseases (Table 2.2) (in 
parentheses the number of publications): 
A. co-existence of diseases without mentioning any reference category (N=13); 
B. presence of diseases other than the index disease (N=12); 
С relationship (association, correlation) between two diseases (N=9). 
Definitions in the classes A and В suggest that a random co-existence of diseases is 
assumed, whereas definitions in the third class are based on a hypothesis of a certain 
relationship. Definitions in class В differ from those in class A in the explicit mention­
ing of an index disease. The definitions in class С give more detail about the kind of 
relationship between the studied diseases. 
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Table 12. Definitions of comorbidity, explicitly mentioned in 33 publications 
Co-existence of diseases without any reference category 
'all chronic conditions they had' [5] 
'presence of multiple health conditions' [6] 
'co-existence of chronic conditions' [7] 
'co-existing diseases at the time of hospitalization' [32] 
'co-existing diseases' [33,42] 
'secondary diagnoses at the hospital discharge' [43] 
'secondary diagnoses listed at discharge that represented chronic disease that would be unlikely to 
occur as in-hospital complication' [52] 
'having several chronic conditions simultaneously' [66] 
'co-existence of multiple diseases and conditions' [67] 
'co-existence of chronic conditions or impairments in the same person' [81] 
'concurrent (pathological) conditions and disorders' [82] 
'diseases occurring together within a 12 month period' [83] 
Presence of diseases other than an index disease 
'presence of one or more of the other 36 health conditions [than the index condition]' [9] 
'other medical conditions that were not specifically identified as possible causes of [the index 
disease]' [10] 
'[index disease] co-existing with other chronic diseases' [11] 
Occurrence of [the index disease] in conjunction with other chronic conditions' [12] 
'other health problems present which could, by themselves or interacting with [the index disease] 
cause [dependent variable]' [13] 
Occurrence of [disease A] in patients with [the index disease]' [IS] 
'medical problems or functional limitations other than those due to [the index disease]' [17] 
'other sources of morbidity that may also influence [the dependent variable]' [19] 
'conditions, other than the patients' [index disease] that may have had an impact on [the outcome 
variable]' [28] 
'presence of other health conditions than [the index disease]' [69] 
'clinical conditions other than [the index disease] that might have been expected to impair [the 
outcome variable]' [76] 
'ailments that co-exist with в "main" disease' [80] 
Relationship (association, correlation) between diseases 
'relationship between [disease X] and [the index disease]' [8] 
'association between [index disease] and [disease XJ' [20,21,65] 
'correlation between [disease X] and [disease Y]' [22] 
'symptomatic associated diseases at the onset of [the index disease]' [26] 
'any associated disease at the time of the [index disease]' [49] 
'complicating conditions' [74] 
'associated conditions [at the same site as the index disease] that might have been responsible for the 
local symptoms attributed to the [index disease]' [76] 
Comorbid diseases 
In 17 of the 70 publications comorbidity was not specified in terms of diagnoses 
[6,12,28,30,32-36,53,55,70,72-74,77,78]. In 14 other publications [7,9,13,19,23,24,29,37,66, 
68,75,79,81,83] the reader, looking for diseases, was referred to references on existing 
instruments as the Supplement on Aging of the National Health Interview Survey [7, 
13,66,81], or indexes as the Comorbidity Damage Index [23,24] and the Charlson Index 
[29,37]. Only the diseases that were mentioned explicitly were considered. Two 
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publications made no restrictions in the diseases that were included under the term 
comorbidity [79,83]. Table 23 lists the diseases that were most frequently mentioned. 
The chronic nature of these diseases is evident Although the index diseases in the 
selected publications differed widely (see Appendix), the authors apparently agreed 
upon the nature of relevant comorbidity in the different studies. It is striking that also 
risk factors as hypertension, smoking, alcohol and drug use were labelled as comorbid 
conditions. 
Table 13. Diseases or disease categories most frequently mentioned in studying comorbidity (number of 
publications in which the disease was mentioned in parentheses) 
Disease or disease category Reference # 
Diabetes mellitus (N=28) 
Hypertension/ 
high blood pressure (N«28) 
Cancer, 
incl. specifications (N=23) 
Ischemic heart disease/ 
angina/myocardial infarction 
(N=16) 
Pulmonary/respiratory/ 
lung disease (N=12) 
Heart disease (N=12) 
Peripheral vascular disease (N= 11) 
Cerebrovascular disease/ 
stroke (N=10) 
Kidney/renal disease (N= 10) 
Congestive heart failure (N=9) 
5,7,8,16,19,21,23,24,26, 
29,37,38,39,41,42,43,44,45, 
46,47,48,49,50,66,67,69,71,81 
7,14,16,19,21,23,24,27, 
29,31,37,38,39,41,42,43,44, 
46,47,49,50,65,66,67,69,71,80,81 
5,7,11,19,20,23,24Д7, 
29,31,37,42,46.48,49,52,54, 
66.67,69,76.80,81 
21,23,24,27,29,37,38,39, 
41,42,43,48,49,65,66,71 
8,19,23,24,29,37. 
47,48,69,75,80,81 
5,7,16,42.46,47, 
50,52,54,69,80,81 
23,24,26.29,37,38, 
39,47,48,52,80 
7,16,27,29,37,38,48,66,67,81 
5,19,23,24,42,48,54,69.75,80 
23,24,27,29,37,38,41,48^2 
In 11 publications the source of data on diseases was not mentioned [14,16,27,28,32-
34, 45,46,49,77] or not relevant (written cases [17] or review [54]). Diseases based on 
self-report were used in 14 publications [5-7,9,12,13,19,44,66-70,81]. Three publications 
reported a special examination [15,65,82] as the basis for determining comorbid 
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diseases. In the other publications comorbidity data originated from medical records 
solely, or in combination with self-report In six publications information was given on 
the applicated diagnostic criteria in diagnosing comorbid diseases [13,22,36,41,65,80]. 
Design 
Most publications in which comorbidity plays a substantial role were cohort studies 
or include a cross-sectional design (Table 2.4). Eight publications regarded the vali-
dation of an index of comorbidity or of an index in which comorbidity is included. None 
of the 70 publications reported a study with a design allowing conclusions about causal 
relations between independent and dependent variables. 
Place of comorbidity in the design 
In 13 publications comorbidity was the main outcome variable (Table 2.4 and 
Appendix). Comorbidity appeared most frequently as an independent variable, less 
frequently as a variable that confounds or modifies the relation between independent 
and dependent variable. 
Table 2.4. Summary of methodological aspects of 70 publications on comorbidity (for full overview see 
appendix) 
Denigri ' 
Cohort study 
Cross-sectional study 
Validation study 
Case control study 
Longitudinal study 
Reliability study 
'Delphi'-process 
Review 
1
 one publication included 2 designs 
Place or junction of comorbidity in the design 2 
Independent variable 
Confounding / Modifying variable 
Outcome variable 
Variable to be validated 
Variable to be compared 
Number of 
publications 
33 
20 
8 
4 
3 
1 
1 
1 
28 
23 
13 
7 
1 
' two publications included more than one function of comorbidity in the study 
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Tabic IA. Summary of methodological aspects of 70 publications on comorbidity (for full overview see 
appendix) - continued 
Number of 
publications 
Measure of comorbidity 3 
Existence of specific diseases 33 
Number (sum) of diseases 18 
Existence of comorbidity 13 
Index of comorbidity 13 
5
 seven publications used two types of measures 
Main outcome variable * 
Mortality or survival 32 
Demand/use of health services, 
incl. type of treatment 13 ~ 
Comorbidity 13 
Disability/functional health 11 
Incident morbidity/complications 10 
Other 14 
4
 a total of 93 different outcome variables were identified 
The index diseases cover a broad variety of diseases or conditions (see Appendix). 
Apparently, comorbidity was a variable of interest in studies on (rheumatoid) arthritis 
(N=11 publications), cardiovascular diseases (N=10), cancer (N=6), and diabetes 
mellitus (five publications). 
Measures of comorbidity 
There were major differences in the way comorbidity was handled in the analysis in 
the 70 reviewed publications (Table 2.4). In almost half of the publications comorbidity 
was included in die analysis as multiple variables, indicating the presence or absence of 
specific diseases or disease categories separately. The number (sum) of comorbid 
diseases is a measure that was mentioned in 18 publications. The use of one variable 
indicating the presence or absence of any comorbid disease is less popular. This is also 
true for the use of an index. A total of five different indexes, which are primarily focus-
ed on comorbidity, were mentioned. The earliest index mentioned in the selected 
publications classified comorbid diseases in grades of severity [80]. This index was the 
basis for a second index, generally referred to as the "Charlson Index", including the 
extent of comorbidity weighted for severity [29]. Greenfield et al. developed an index 
for comorbidity weighted for the stage of disease, complications, and functional status 
[28]. Two publications mentioned an index which was apparently specifically developed 
for that study [17, 73]. 
Mortality or survival is the outcome variable most studied in publications regarding 
comorbidity. 
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2.4. Discussion 
A systematic search in MedLine by meaos of a key word that is a non-Index 
Medicus term carries the risk of being incomplete. Another reason for possible 'under-
selection' is the assignment of key words by the authors. It can be assumed that 
comorbidity is used in many more studies. By selecting publications on the basis of the 
term comorbidity as key word, bias due to the authors by not assigning comorbidity as 
key word or by not mentioning it in the abstract cannot be excluded. To fill this gap, all 
references of the selected publications were systematically screened, resulting in the 
additional 16 eligible publications. Several authors are represented more than once in 
our selection; screening bibliographical indexes using these authors' names could 
perhaps reveal more publications. 
Definition of comorbidity 
In contrast with the term multiple diseases or multiple pathology, the term 
comorbidity suggests the existence of an index disease as starting point, and that there 
are other diseases at the same time in the same patient [84]. The relation between the 
index disease and the comorbid disease(s) is obviously the basis for the definitions of 
comorbidity in the reviewed publications. 
A previously proposed classification of comorbidity [84] was based upon the impact of 
comorbidity in different clinical situations, e.g. comorbidity that hinders the diagnostic 
process, or comorbidity influencing the prognosis of an established disease. 
The following classification that is being developed, is based upon the type of the 
assumed relationship between diseases. It consists of four categories: 
a. concurrent comorbidity: the co-existence of diseases in the same person without any 
satisfying explanation, e.g. cardiovascular disease and osteoarthritis; 
b. cluster comorbidity: the distribution of diseases in a population shows concentrations 
in subgroups that differ significantly from the distribution by chance, e.g. multiple 
sclerosis and epilepsy [IS]; 
с causal comorbidity: interrelation of diseases based on a proven common 
pathophysiological cause, e.g. ischemic heart disease and peripheral arterial disease; 
d. disease-specific complicating comorbidity: the existence of one disease is obligatory 
for the occurrence of another disease, e.g. diabetes mellitus and diabetic 
retinopathy. 
This classification structures the relationship between an index disease and one or more 
other diseases. 
Whether and which types of comorbidity are relevant in a certain study depends 
mostly on the questions to be answered. Concurrent comorbidity is potentially relevant 
for clinical practice, e.g. when the presence of one disease is a contra-indication for the 
pharmacological treatment of a second disease. Cluster comorbidity is an interesting 
phenomenon for clinical researchers and can turn out to be important in describing a 
new syndrome [85]. Causal comorbidity and complicating comorbidity are clinically 
relevant for the management of diseases and their complications, for surveillance, and 
foT screening and prevention. 
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Comorbld diseases 
A substantial number of the publications agree upon the diseases that constitute 
comorbidity: mostly chronic diseases with a high prevalence. Apparently, acute medical 
conditions are considered to be less relevant co-morbid diseases. The inclusion of risk 
factors (e.g. smoking, alcohol abuse) as comorbid diseases is dubious. When they are 
separately considered in a study, it is not necessary to label them as comorbid condi-
tions. When they are included in a variable at a more aggregated level as an index, it is 
questionable whether this information is comparable with other variables constituting 
mat index. 
In only a small minority of the publications the application of diagnostic criteria in 
confirming the existence of comorbid diseases was explicitly mentioned. This raises 
questions about the validity of morbidity data that are used in the other publications, 
especially when the information originates from self-report [86-88]. 
Methodological aspects 
The question of which diseases should be considered in terms of comorbidity 
depends, of course, on the function of the variable 'comorbidity' in the study (inde-
pendent variable, dependent variable or confounder/modifier). In general, it is recom-
mended to specify beforehand in detail which diseases or conditions are relevant within 
the context of the study. Global measures, such as the number (sum) of diseases or 
conditions, seem to be a relevant predictor (see, for example [81]). However, when 
more detailed measures are used, results can more easily be interpreted and are 
probably more relevant in practice. 
2.5. Conclusions 
Comorbidity has been given increasing attention in literature and research. It seems, 
however, that every author uses his own definition of comorbidity and handles 
comorbidity by his own method. Explicit mentioning of definition, diseases considered, 
and of analytic methodology in the management of comorbidity in research publications 
would be an important first step on the road towards standardization. The usefulness of 
a distinction between 'causal comorbidity' and 'comorbidity by chance' needs further 
study. 
This review is an exploration in the complex world of comorbidity. It is an attempt to 
introduce a systematical approach that hopefully will stimulate further creative concept-
ual and research work in Âis field. 
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Э. Validity of diagnoses of chronic diseases in general 
practice 
The application of diagnostic criteria 
... Diagnostic labels are a kind of clinical shorthand; 
they are based on agreement and on generally accepted 
defining criteria; they have no intrinsic value...' 
Abstract - Certainty of a diagnosis is not only important for the patient but also for 
morbidity studies. In the absence of a gold standard, agreement with diagnostic criteria L· 
often the best approach in measuring the certainty of a diagnosis. The agreement with 
diagnostic criteria has been studied for 5 chronic diseases (hypertension, chronic ischemic 
heart disease, diabetes mellitus, chronic nonspecific lung disease and osteoarthritis) in 7 
general practices with a total practice population of 23,534 persons. Agreement with 
diagnostic criteria is operationalized into 3 categories. For each chronic disease a diagnostic 
quality measure per general practitioner is computed Retrospective data have been collected 
in the practices on 2295 diseases in 1989 patients. Two-thirds of the diagnoses were made 
in general practice. The agreement with the diagnostic criteria for the cases diagnosed in 
general practice is high, ranging from 96% true positive cases in diabetes mellitus to 58% in 
chronic nonspecific lung disease. The highest rate of f abe positive cases L· 4%. On the level 
of general practitioners diagnostic qualities vary from 62 to 96% true positive cases for the 
different diseases. The variation in diagnostic quality between general practitioners is 
substantial. The prevalence rates for the 5 chronic diseases are lower after adjustment by 
only including true positive cases. Diagnoses of the 5 chronic diseases recorded in general 
practice are generally valid with low numbers of false positive cases. 
' Sluiter HJ, Koëter GH, Monchy JGR de, Postma DS, Vries К de, Orie NGM. The 
Dutch hypothesis (chronic non-specific lung disease) revisited Eur Respir J 1991,4:479-
489. 
ThL· chapter has been published as: · 
Schellevis FG, Lisdonk E vd, Velden J vd, Eijk JThM v, Weel С v. Validity of diagnoses of 
chronic diseases in general practice. J Can Epidemiol 1993;46:461-468. 
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3.1. Introduction 
The management of chrome diseases is considered to be the 'Very stuff of general 
practice" [1]. The diagnostic process and long-term сате are two major clinical aspects 
of managing chronic diseases in general practice. 
An increasing number of publications deals with various aspects of the long-term 
care of patients with chronic diseases: the organization of care and the management of 
chronic diseases [2], standards in view of the quality of care [3], and compliance with 
therapy and follow-up controls [4]. Much less attention has been given to the process of 
diagnosing a chronic disease in general practice. Yet the diagnosis of a chronic disease 
is of great importance: it labels the patient, often for his lifetime, and often has 
implications for daily life. Those suffering from a chronic disease are at risk of complex 
or serious illness, and of potentially harmful medical interventions. Therefore, the 
certainty of the diagnosis of a chronic disease is of crucial importance: false-positive 
and false-negative diagnoses may have unacceptable consequences for the patient 
Apart from the importance of accurate diagnoses for the patient, certainty of the 
diagnosis is important for epidemiological research. This is especially the case in coun­
tries like the U.K. and The Netherlands where all non-institutionalized persons are 
registered in a general practice, which allows a valid estimation of the epidemiological 
denominator. Estimations of morbidity rates often rest upon population surveys with 
self-report about diseases. In measuring the concurrent validity of these, data a compari­
son is often made with morbidity data from medical sources on the assumption that the 
latter data have a higher validity [5-7]. 
The aim of this study was to establish the validity of the diagnoses of chronic 
diseases on medical records in general practice. 
Unfortunately, there is no absolute certainty or "gold standard" for diagnoses, 
except for some areas where diagnostic criteria are linked to underlying pathologic 
confirmation. Therefore, agreement with a set of diagnostic criteria is usually the best 
approach. Diagnostic criteria, often determined by international expert fora, reflect the 
actual common consensus on the nature and outcome of diagnostic procedures 
determining the diagnosis. The International Classification of Health Problems in 
Primary Care (ICHPPC) [8] lists diagnostic criteria to be used in general practice. 
The application of such criteria in diagnosing chronic diseases in general practice 
has not been widely studied. A pilot study performed in Maastricht (The Netherlands) 
to evaluate the feasibility of application of criteria in daily work in general practice 
provided encouraging results [9]. 
We have compared information on applied diagnostic procedures by general 
practitioners in diagnosing patients with hypertension, chronic ischemic heart disease, 
diabetes mellitus, chronic nonspecific hing disease, and osteoarthritis of hip and/or knee 
with the diagnostic criteria of the ICHPPC-2. We also describe the effects of only 
including true positive cases on the prevalence rates of these chronic diseases. 
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3.2. Methods 
Practices and population 
From 103 practices that took part in the "Dutch National survey of morbidity and 
interventions in general practice" [10] (a non-proportional stratified random sample of 
all general practitioners in the Netherlands) 8 practices were selected and invited to 
participate in a follow-up project on chronic diseases. The selection was based on the 
period of participation in the national survey (third and fourth trimester of the 1-year 
period of data collection) and the location of the practice (south-east part of the 
country). The reason for selecting this part of the country was that from this region the 
Department of General Practice of Nijmegen recruits practices for educational and 
research purposes. One practice (3 general practitioners (GP)) refused participation for 
reasons of the expected high workload. Two of the 7 participating practices are single-
handed, 4 have 2 GPs and 1 is a group practice with 5 GPs. In 1988, 56% of the Dutch 
GPs worked in single-handed practices, 30% in duo-practices and 14% in group 
practices or health centers. Three of the participating practices are involved in voca-
tional general practice training, the others have no special relationship with a university 
department of general practice. 
In each practice an age/sex register was compiled with the help of trained students. 
On 1 January 1988 the 7 practices covered 23,534 people. Table 3.1 lists some popula-
tion characteristics for these practices compared with the total population of The 
Netherlands. 
Information on the distribution in the population of the practices of risk factors for 
chronic diseases, like body weight, blood pressure, cholesterol, nutrition and smoking 
habits, is not available. 
Identification of cases 
In each practice the general practitioners were asked to identify from the practice 
list all patients with any of the following diseases: 
hypertension 
chronic ischemic heart disease (angina pectoris, previous myocardial infarction, 
coronary sclerosis) (CIHD) 
diabetes mellitus 
chronic nonspecific lung disease (asthma, chronic bronchitis, emphysema) (CNSLD) 
osteoarthritis of hip and/or knee. 
Criteria for identification were: the patient was currently known by the GP or by 
notation on the patient's record as having any of the chronic diseases mentioned and 
the diagnosis was made before 1 January 1988. Identification of patients was a two-step 
process. 
Firstly, identification was made on the occasion of an encounter, a repeat prescrip-
tion or other administrative reason for one of the chronic diseases during the first 3 
months of the study, resulting in 1073 patients. In the second step the GP reviewed 
systematically the patient records of all patients on the practice list who had not had 
contact with the practice during the previous 3 months. Another 916 patients were 
identified in this way, resulting in a total number of 1989 patients with 2295 diseases. 
These figures imply the presence of more than one of the chronic diseases in 1 out of 6 
patients. At the time of the identification of patients the GPs were not aware of the aim 
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of the study, nor bad they discussed the diagnostic criteria. 
Table 3.1. Characteristics of the population of the 7 study practices (N=23,534) compared to the popula-
tion of The Netherlands (N«14,714,948) on 1 January 1988; percentages 
Population characteristics Study practices The Netherlands 
Age 
0-4 
5-14 
15-24 
25-44 
45-64 
2: 65 
5.4 
12.9 
17.3 
35.8 
193 
93 
6.1 
12.4 
16.8 
31.9 
20.4 
12.5 
Sex 
Male 48.8 
Female 51.2 
Health core insurance (income-related) 
Healt Care Fund members 68.6 
Privately insured or not insured persons 31.4 
Country of birth 
The Netherlands 97.1 
Turkey/Marocco 03 
Other Western countries 0.9 
Other non-Western countries 1.7 
Highest educational level (only persons i 18: 72.4%) 
No education/primary school . 26.2 
Secondary school 61.9 
University 11.9 
Socioeconomic doss (profession) (missing data: 25.6 %) 
Brain work: high/middle 23.8 
Brain work: low class 20.9 
Farmers / independent business 83 
Hand work: high/middle 23.9 
Hand work: low class 23.2 
49.4 
50.6 
61.0 
39.0 
96.0 
2.0 
\2 
0.8 
20.9 
62.8 
163 
26.1 
24.4 
5.7 
21.5 
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Information on diagnostic procedures 
In a questionnaire for each patient and each disease the GPs were asked to supply: 
thè diagnostic procedures used, the date of diagnosis, and the diagnosing physician (GP 
or specialist). They were asked to consult all available sources of information such as 
patients' records and archives. In answering the questions the GPs were instructed that 
any "Yes" had to be based on written information on patient history, physical examin-
ation or diagnostic tests. Any available information was considered relevant for this 
study as the diseases involved are chronic and lasting. In collecting these retrospective 
data we set no limitation in time. 
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The questions regarding the diagnostic procedures were derived from the I C H P P C -
2 diagnostic criteria as is shown in Table 3.2. 
Table 32 . ICHPPC-2 diagnostic criteria and corresponding questions per disease 
ICHPPC-2 diagnostic criteria Questions 
Hypertension 
* Blood pressure at two readings > 160/95 mm Hg 
Chronic ischemic heart disease 
* Old myocardial infarction history, ECG or 
X-ray evidence 
* Chest pain compatible with angina pectoris 
* ECG evidence of myocardial ischemia or 
ventricular aneurysm 
* X-ray evidence of narrowed coronary arteries 
or ventricular aneurysm 
Diabetes mellitus 
* Blood glucose level: 
- fasting a 8.0 mmol/l 
- not fasting a 11.0 mmol/l 
* Classic symptoms 
CNSLDI Asthma 
* Variable obstruction at pulmonary function test 
* Wheeze, dry cough, prolonged expiratory phase 
CNSLD I Chronic bronchitis 
* History of cough with purulent sputum 
* Scattered rales or ronchi on auscultation 
Date encounters? 
Blood pressure (mm Hg)? 
Diagnosis based on 
- history (Y/N)? 
- ECG (Y/N)? 
Blood glucose level (mmol/I)? 
Condition at the time of taking the sample: 
(fasting, 2 h after meal, glucose tolerance 
test, arbitrary occasion)? 
Diagnosis based on 
- history (Y/N)? 
- physical examination (Y/N)? 
. pulmonary function test (Y/N)? 
- X-ray (Y/N)? 
* See Asthma 
CNSLD I Emphysema 
* X-ray evidence 
* Obstruction at pulmonary function test 
* Dyspnea 
* Shape of chest with reduced breath sounds 
Osteoarthritis hip/knee 
* X-ray evidence 
* Joint disorder with 
- irregular swelling 
- crepitation 
- stiffness/limited movement 
- normal laboratory test 
-age 
* See Asthma 
Diagnosis based on 
- history (Y/N)? 
- physical examination (Y/N)? 
- laboratory test (Y/N)? 
- X-ray (Y/N)? 
Validity measure 
A measure of validity for each chrome disease was determined by comparing the 
reported procedures with the diagnostic criteria. Agreement with the diagnostic criteria 
is categorized (Table 3.3): 
(a) full agreement (true positive) 
(b) partial agreement 
(c) no agreement (false positive). 
This measure of validity was used for analysis on case level If no data on the 
diagnostic criteria were available, the case was designated as "missing". The ICHPPC-2 
diagnostic criteria for diabetes mellitus and hypertension list cut-off points of numeric 
values. For the other diseases the criteria are of a descriptive nature, allowing only a 
qualitative judgement of the diagnostic validity. 
Table 3 3 . Categories of agreement with the diagnostic criteria 
Full agreement Partial agreement 
Hypertension 
* DBP £ 95 mm Hg at two encounters * DBP £ 95 mm Hg at one encounter 
Chronic ischemic heart disease 
* Diagnosis based on ECG * Diagnosis based only on history 
Diabetes mellitus * 
* Blood glucose level: not categorized 
- fasting: £ 8,0 mmol/1 or 
- not fasting: £ 11,0 mmol/1 
CNSLD 
* Diagnosis based on pulmonary function test * Diagnosis based only on history and physical 
or X-ray examination 
Osteoarthritis hip I knee 
* Diagnosis based on laboratory test or X-ray * Diagnosis based only on history and physical 
examination 
General practitioner's diagnostic quality . 
Data on diagnostic procedures performed in diagnosing chronic diseases in patients 
of any one GP have to be considered interdependent: the diagnostic process is likely to 
be a physician characteristic rather than a patient characteristic. Consequently, the 
validity measures for the different chronic diseases are aggregated on the GP level [11]. 
A diagnostic quality measure was computed by dividing the number of true positive 
cases by the total number of identified cases per general practitioner, expressed in 
percentages. The influence of characteristics of GP (gender) and practice (practice type, 
distance between practice office and nearest hospital, and urbanization level of the 
community in which the practice is located) on this diagnostic quality measure is 
analyzed by means of subgroup analysis, comparing means in subgroups by univariate 
analysis and by calculating the statistical significance with the 2-tailed probability at the 
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5% level. 
Prevalence 
The prevalences reflect point-prevalences: the number of disease cases per 1000 in 
the population on 1 January 1988. As the information on morbidity was derived from 
general practice records, the time period for measuring prevalence for each patient was 
potentially lifelong. The mean duration of the diseases on 1 January 1988 varied from 4 
to 9 years. 
The prevalences of the chronic diseases are based on the diseases of the identified 
patients ("unadjusted" prevalence). Adjustment was carried out by only taking into 
account true positive cases. 
3.3. Results 
The cooperation of the GPs was satisfying, considering the intensive search for data 
in archives and patient files that had to be made. No data about the applied criteria 
could be traced in 17 % of the diagnoses. In S % of the diagnoses it is unknown 
whether it was made by a GP or by a specialist 
Validity of diagnoses 
Table 3.4 shows the agreement of the applied procedures with the ICHPPC-2 
diagnostic criteria for all cases diagnosed by GPs (63% of all diagnoses). The agree-
ment is high in cases of diabetes mellitus (96% true positive cases), hypertension (85%) 
and osteoarthritis (81% true positive). Partial agreement is a substantial category in 
CIHD and CNSLD. The category "no-agreement with the diagnostic criteria" (the false 
positive cases) is highest in diabetes mellitus (4%). 
Table 3.4. Agreement of the performed diagnostic procedures with the diagnostic criteria (in percentages 
of the cases for each disease) - only cases diagnosed by the GP 
Agreement 
No. of 
cases 
(abs) 
(719) 
(194) 
(172) 
(292) 
(68) 
Full 
% 
85.1 
67.9 
96.1 
57.6 
80.6 
Part 
% 
12.6 
29.9 
-
42.4 
19.4 
No 
% 
23 
2.2 
3.9 
0.0 
0.0 
Missing 
data 
(abs) 
(75) 
(10) 
(44) 
(35) 
(6) 
Hypertension 
Chronic ischemic heart disease 
Diabetes mellitus 
Chronic nonspecific lung disease 
Osteoarthritis hip/knee 
In patients whose diagnosis was made by a specialist (results not shown) data is 
often missing, especially in hypertension and diabetes mellitus. The specialists' diag-
noses in patients with CIHD and CNSLD are more in agreement with the ICHPPC-2 
criteria than cases diagnosed by GPs (85 vs 68% and 81 vs 58%, respectively). In 
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diabetes mellitus diagnosed by specialists the agreement is lower (82 vs 96% in GPs' 
diagnoses). 
Diagnostic quality 
In Table 3.3 the diagnostic quality measures of the participating GPs are summar­
ized. The general practitioners diagnosed hypertension, diabetes mellitus, ischemic heart 
disease and osteoarthritis in more than 70 % of the cases in full agreement with the 
criteria; in chronic hing disease the diagnostic quality is lower. The relatively small 
confidence intervals in diabetes mellitus and hypertension indicate little variation 
between the general practitioners. 
Further analysis of the diagnostic quality measure in subgroups defined by GP and 
practice characteristics shows significant differences (p < 0.05) only on the variables 
"single-handed and duo practice" vs "group practice" (GPs from the group practice 
scored lower in CIHD and CNSLD) and urbanization level of the community served 
(GPs in suburbanized communities scored lower for CIHD and CNSLD). There was no 
correlation between the diagnostic quality ratios for the different diseases for the 
individual GP (data not shown). 
ТвЫе 3.5. Mean diagnostic quality (percentage of true positive cases) of the participating general 
practitioners (N= 15) per chronic disease. Percentages and 95% confidence intervals 
No. of True 
patients positive 
(abs) (%) 95% CI 
Hypertension 
Chronic ischemic heart disease 
Diabetes mellitus 
Chronic nonspecific lung disease 
Osteoarthritis of hip/knee 
(644) 
(184) 
(128) 
(257) 
(62) 
85.5 
763 
97.6 
62J 
84.0 
81.0-90.1 
58.4-943 
95.6-99.6 
443-80.7 
71.1-96.8 
Prevalence 
Table 3.6 summarizes the prevalence of the chronic diseases, regardless of whether 
the diagnosis was made in general practice or by a specialist, in relation to agreement 
with the diagnostic criteria. The prevalence rates are computed for two age-groups: < 
65 and 2 65 years old. Adjustment by only including true positive cases lowers the 
prevalence of all chronic diseases. 
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Table 3.6. Point-prevalence and 95% confidence intervals unadjusted and adjusted (true positive cases 
only) in people < 65 (N=21,349) and 2 65 years (N=2185) of 5 chronic diseases in the study practices 
per 1000 patients 
< 65 years 
Unadj. 95% α Adj. 95% CI 
Hypertension 
Chronic ischemic heart disease 
Diabetes mellitus 
Chronic nonspecific lung disease 
Osteoarthritis hip/knee 
24.7 
10.9 
73 
19.9 
11 
22.6-26.8 
9.5-123 
6.1-8.4 
18.0-21.0 
U-2.8 
18J 
7.5 
43 
1Z2 
1.7 
16.6-203 
6.4-8.7 
3.4-5.1 
10.8-13.7 
1.1-2.2 
£ 65 years 
Unadj. 95% α Adj. 95% CI 
Hypertension 
Chronic ischemic heart disease 
Diabetes mellitus 
Chronic nonspecific lung disease 
Osteoarthritis hip/knee 
143.2 
100.2 
60.9 
65.4 
38.0 
129.0-158.0 
87.6-И3.0 
51.2-71.7 
55.5-76.6 
30346.8 
89.7 
75.1 
33.0 
43.5 
29.3 
78.1-102.0 
64.4-86.9 
25.8-413 
353-52.9 
22.6-373 
3.4. Discussion 
Validity 
Diagnoses of chronic diseases made by GPs agree very well with the diagnostic 
criteria of the ICHPPC-2-Defined. The highest rate of false positive cases is 4% 
(diabetes mellitus). 
In the case of diabetes mellitus, it should be taken into account that the widely used 
diagnostic criteria changed in 1980 to more stringent ones [12]. In this study 4 out of 
the 14 false positive cases of diabetes mellitus were diagnosed before 1980. 
The number of cases with CIHD and CNSLD diagnosed on the basis of history and 
physical examination ('partial agreement") is relatively high. This reflects the common 
diagnostic procedures in general practice in The Netherlands where electrocardio­
graphic and spirometrie examinations are not available in general practice. Apparently 
GPs consider the patient's history, and signs and symptoms at physical examination to 
be a sufficient basis for diagnosing these cardiac and respiratory diseases. 
For many patients osteoarthritis is a silent disease: only patients with complaints or 
symptoms consult a GP, and the GP will only report on these cases. Consequently, in 
this study probably only osteoarthritis patients with complaints were included as being 
"at risk" for undergoing X-ray examination. This is reflected in the high percentage of 
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true positive cases of osteoarthritis. 
The number of missing data is acceptable, considering the retrospective nature of 
the collected data. Moreover, for the diagnoses made by medical specialists, it should 
be kept in mind that patients in The Netherlands will only come under the care of a 
specialist upon referral by a GP. The medical specialist usually reports his diagnosis to 
the GP, but does not always include the criteria upon which the diagnosis is based. 
Routine general practice care does not necessarily imply detailed documentation of 
performed diagnostic procedures. As this study is based on recorded evidence the level 
of agreement with diagnostic criteria is an underestimation of validity. The "partial 
agreement" category, for example, probably includes a number of true positive cases. 
This could be verified by performing additional diagnostic procedures. Moreover, we 
have no information on false negative cases. 
We suggest that agreement with international standard diagnostic criteria for 
general practice is the best way to assess the validity of the diagnosis. The diagnostic 
criteria of the ICHPPC-2-Defined seem to be useful in assessing the quality of diag-
noses, although difficult to use in qualitative retrospective data. Operationalization of 
these criteria for use in research needs further elaboration. 
Diagnostic quality 
The diagnostic quality per chronic disease varies substantially between the GPs. 
When the results on validity are aggregated from the patient level to the level of the 
GP the mean percentages do not change very much. The confidence intervals, however, 
are larger because of the sample size (15 GPs). This is especially the case for CIHD 
and CNSLD, which is possibly explained by differences between general practitioners in 
the use of clinical diagnostic facilities (electrocardiography and spirometry). 
We find no support in our data for the assumption that there is a general diagnostic 
ability of GPs reflected in a correlation between the quality ratios for different diseases, 
but the number of general practitioners in our study is too small for definitive con-
clusions. 
Prevalence 
Substantial differences in prevalences are found by adjustment for true positive 
cases only, mainly due to the number of missing cases left out The age-specific 
adjusted prevalence rates of the chronic diseases are lower in this study than those in 
other morbidity surveys in general practice in The Netherlands [13,14]. On the patient 
level our sample can be considered representative for the entire population of The 
Netherlands. On the level of practices the sample is too small to allow generalization. 
For chronic lung disease the differences in prevalence in morbidity surveys reflect 
the differences in definition between The Netherlands and the U.K. [15,16]. 
Osteoarthritis of hip and/or knee is probably the most underreported chronic 
disease in this study, because only patients with complaints are seen. Comparison with 
other morbidity data is difficult as generally all cases of osteoarthritis are reported 
without specifying the affected joints. 
These discrepancies can be explained by differences between GPs in registration 
discipline [17], differences in case-finding, differences in applying diagnostic criteria or 
by real morbidity differences between populations. We have no information about 
applied diagnostic criteria in these large surveys. We have no reason to suppose that 
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the population of our study practices differs that much from other populations that the 
studied diseases really occur less frequently. 
3.5. Conclusions 
Diagnoses of the 5 chronic diseases recorded in general practice are generally valid 
with low numbers of false positive cases. The diagnosing physician as source of 
variability in the validity of diagnoses should not be ignored. The validity of morbidity 
data originating from population surveys can well be measured by comparison with GPs' 
records. 
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4. Comorbidity of chronic diseases in general practice 
... The 'doctrine of the singU diagnosis'found 
no piace in the interpretations of these diseases, 
characterised as they were by their multiplicity...' 
Abstract - With the increasing number of elderly people in The Netherlands the prevalence 
of chronic diseases will rise in the next decades. It is recognized in general practice that 
many older patients suffer from more than one chronic disease (comorbidity). The aim of 
this study is to describe the extent of comorbidity for the following diseases: hypertension, 
chronic ischemic heart disease, diabetes mellitus, chronic nonspecific lung disease, 
osteoarthritis. In a general practice population of 23,534 persons 1989 patients have been 
identified with one or more chronic diseases. Only diseases in agreement with diagnostic 
criteria were included. In persons of 65 and older 23% suffer from one or more of the 
chronic diseases under study. Within this group 15% suffer from more than one of the 
chronic diseases. Osteoarthritis and diabetes mellitus are the diseases with the highest rate of 
comorbidity. Comorbidity restricts the external validity of results from single-disease 
intervention studies and complicates the organization of care. 
WUson LA, Lawson IR, Brass W. Multiple disorders in the elderly. Lancet 1962;Ш841-
843. 
This chapter has been published as: 
Schellevis FG, Velden J vd, Lisdonk E vd, Eijk JThM v, Weel С v. Comorbidity of chronic 
diseases in general practice. J Clin Epidemiol 1993;46:469-473. 
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4.1. Introduction 
The morbidity pattern in general practice is well-documented, particularly in The 
Netherlands and in the U.K., where the fixed practice population allows for population-
based description [1-4]. 
General practice covers its own clinical spectrum as has been demonstrated 
previously [5]. Chronic diseases are an important feature of this clinical spectrum: 
hypertension, chronic ischemic heart disease, diabetes mellitus, chronic nonspecific lung 
disease, and osteoarthritis all have a prevalence above 10 per 1000 and are mostly 
managed in general practice [3,4,6,7]. In the near future the number of elderly people 
will increase in the Netherlands. As a consequence, the prevalence of chronic diseases 
will rise. 
These changes in morbidity pattern will influence the daily work in general practice. 
Standards and guidelines for proper diagnosis, treatment and management of chronic 
diseases are crucial for maintaining the quality of care. Intervention studies provide an 
essential basis for adequate treatment and prevention. Most of such studies analyze the 
effects of intervention on a single disease. General practitioners (GPs), however, 
recognize that their patients often suffer from more than one chronic disease. As a 
generalist the GP, alone or in cooperation with the specialist, deals with all diseases of 
a patient As the natural course and the therapeutic interventions of one disease will 
influence the co-existing second (or even third) disease [8], comorbidity diminishes the 
practical value of single-disease standards for treatment and management, derived from 
single-disease trials. We found no publications on the frequency of comorbidity in 
general practice populations. The aim of this study is to describe the extent of 
comorbidity of chronic diseases in general practice in The Netherlands: how many of 
the patients are under care for more than one of the following, most common, chronic 
diseases: hypertension, chronic ischemic heart disease, diabetes mellitus, chronic 
nonspecific lung disease, and osteoarthritis? 
The findings indicate the prevalence of these problems and thus contribute to our 
insight in disease clustering [9]. 
4.2. Methods 
This study is part of a larger research on the prevalence of chronic diseases in 
general practice, and of the effects of systematic surveillance on the quality of care. 
General practices and population 
Seven genera] practices (IS GPs) participated in the study. The practices covered 
23,534 persons at the start of the data collection (1 January 1988). An age/sex register 
of the practices was completed with the help of trained students. The number of 
persons of 65 years and over is 3% less than in the entire country (9.3 vs 12.5% - Table 
4.1). For that reason all results are presented for two subpopulations: that of persons 
below 65 and that of persons of 65 and over. In other characteristics the practice 
population differs only marginally from the entire population [10]. 
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Case Identification 
The participating GPs identified all patients known to them with the following 
diseases: 
hypertension 
diabetes mellitus 
chronic ischemic heart disease (CEHD) (angina pectoris, previous myocardial 
infarction, coronary sclerosis) 
chronic nonspecific hing disease (asthma, chronic bronchitis, emphysema) (CNSLD) 
osteoarthritis of hip and/or knee. 
Identification took place on the occasion of a consultation, a repeat prescription or 
another administrative reason for visiting the practice during the first three months. 
Finally, the general practitioner reviewed systematically all patient records to identify 
diseases of patients who were not seen. 
This process of identification resulted in a total number of 1989 patients with 2295 
diseases (cases). 
Table 4.1. Age and sen distribution of the population of the general practices studied (N=23,534) 
compared to the population of The Netherlands (N-14,714,948) 1 January, 1988 
Practice 
population The Netherlands 
(%) (%) 
0-4 5.4 6.1 
5-14 12.9 1Z4 
15-24 173 16.8 
25-44 35.8 31.9 
45-64 19.3 20.4 
г 65 93 12.5 
Male 48.8 49.4 
Female 51.2 50.6 
Application of diagnostic criteria 
The GP provided retrospective data of the medical history from the patients' 
records in relation to the diagnostic procedures applied in diagnosing the chronic 
disease, regardless of whether the diagnosis was made in general practice or by a 
medical specialist These data were compared with the inclusion criteria of the Inter­
national Classification of Health Problems in Primary Care [10,11]. Only the cases 
(diseases) meeting these inclusion criteria were used for analysis. 
Analysis 
Comorbidity of chronic diseases is defined as the "point-prevalent concurrence" of 
the studied diseases known to the participating GPs. Point-prevalence reflects the 
number of diseases in the population at 1 January 1988. Comorbidity was analyzed on 
patient level by means of the multiple response technique in SPSS [12]. Comorbidity is 
expressed as the number of the studied diseases per patient, the mean number of 
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diseases per patient in each disease category, and the proportion of patients with at 
least one of the other diseases. Due to the cross-sectional measurement and the method 
of presentation, patients with comorbidity appear in each of the disease categories that 
apply to them and are therefore counted more than once (e.g. a patient with diabetes 
and with hypertension appears in the hypertension group as well as in the diabetes 
category). Proportions and means are presented with the 95% confidence intervals (CI). 
4.3. Results 
Our definition of comorbidity is strongly connected with the prevalences of the 
studied diseases. Table 4.2 lists the point-prevalences on January 1, 1988 of the diseases 
meeting the inclusion criteria. The prevalence of most diseases is high in persons over 
65. Hypertension is the most frequent of the studied diseases. Table 4.3 shows the 
distribution of the number of the diseases per patient In the younger subgroup there 
are few persons known to have one of the studied diseases, and comorbidity occurs in 
only 0.3% of these persons. Of the persons over 65 years old, more than 75% are 
known not to have one of the 5 chronic diseases, but of the older patients who do have 
one of these diseases, 16% has more than one chronic disease. 
Table 4.2. Point-prevalence in persons < 65 (N=21,349) and 2 65 (N=2185) of 5 chronic diseases per 
1000 petsons in the general practices studied 
Hypertension 
CIHD 
Diabetes mellitus 
CNSLD 
Osteoarthritis hip/knee 
< 
Prevalence 
18.5 
15 
43 
\гі 
1.7 
65 
95% α 
16.6-203 
6.4-8.7 
3.4-5.1 
10.8-13.7 
1.1-2.2 
Table 43. Number of studied chronic diseases per person in 
Number of 
chronic diseases 
None 
One 
Two 
Three 
Four 
< 65 
(N=21349) 
(%) 
95.9 
3.8 
03 
<0.1 
-
2: 65 
Prevalence 95% Q 
89.7 
75.1 
33.0 
43.5 
29.3 
the population 
2 6Í 
(N=2185) 
(%) 
76.9 
19.5 
32 
03 
<0.1 
78.1-102.0 
64.4-86.9 
25.8-413 
353-52.9 
22.6-373 
of the general practices 
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Tables 4.4 (A) and (B) show the extent of comorbidity in patients with at least one 
disease for the two age groups. In patients under 65 years old patients with 
osteoarthritis have the highest rate of comorbidity. The most frequent second disease in 
these patients is CNSLD (5 of 36 patients). In diabetics under 65 (N=91) hypertension 
is the most frequent second disease (15%). In patients of 65 years and older die highest 
frequency of comorbidity is found in patients with diabetes mellitus. The most frequent 
second chronic disease in diabetics over 65 is СПГО (22%), followed by hypertension 
(19%). High rates of comorbidity are also found in patients with osteoarthritis (mostly 
hypertension and CNSLD) and CIHD (mostly hypertension). 
Tabic 44 (A). Extent of comorbidity per disease for patients < 65, presented as number of chronic 
diseases per patient group and as fraction of patients with comorbidity per patient group 
N 
Number of chronic 
diseases per patient 
Mean 95% α 
1.1 1.07-1.13 
12 1.14-1.28 
12 1.13-133 
1.1 - 1.04-1.11 
13 1.12-1.43 
Fraction of 
patients with 
comorbidity 
%ofN 
9.6 
19.9 
20.9 
7.6 
27.8 
Hypertension - 394 
CIHD 161 
Diabetes mellitus 91 
CNSLD 250 
Osteoarthritis hip / knee 36 
Table 4.4 (B). Extent of comorbidity per disease for patients Ь 65, presented as number of chronic 
diseases per patient group and as fraction of patients with comorbidity per patient group 
Hypertension 
CIHD 
Diabetes mellitus 
CNSLD 
Osteoarthritis hip/knee 
N 
196 
164 
72 
93 
64 
Number of chronic 
diseases per patient 
Mean 
13 
13 
1.5 
13 
1.4 
95% α 
1.18-132 
1.24-1.42 
132-1.62 
1.18-1.42 
1.22-1.50 
Fraction of 
patients with 
comorbidity 
%olN 
21.9 
28.0 
40.3 
24.7 
32.8 
CIHD = chronic ischemic heart disease; CNSLD = chronic nonspecific lung disease. 
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4.4. Discussion 
Prevalence of chronic diseases 
This study is based on data obtained from medical records. Generally this leads to 
an underestimation of the number of cases in the population. Moreover, only cases in 
agreement with diagnostic criteria were included. The prevalence of hypertension, 
chronic ischemic heart disease, diabetes mellitus, and chronic nonspecific hing disease is 
lower than in other Dutch reports from general practice [3,4]. Compared with data 
from the U.K., the prevalence of diabetes mellitus is higher, as has been reported by 
others [13]. 
Chronic nonspecific hing disease has been identified as an area of diagnostic 
confusion. Differences in opinion between physicians in the U.K. and The Netherlands 
exist as to whether asthma, chronic bronchitis and emphysema have the same 
pathophysiological characteristics, the so-called Dutch, hypothesis, which is heavily 
disputed [14,15]. As Dutch GPs are familiar with the diagnostic label of chronic 
nonspecific hing disease, this term is used in our description of comorbidity. 
Extent of comorbidity 
Comorbidity is a quantitatively important phenomenon in patients over 65 with a 
chronic disease. Most people over 65 (77%) do not suffer from any of the 5 most 
common chronic diseases, but within the affected group 16% is known to suffer from at 
least one other of the 5 chronic diseases studied. 
The occurrence by chance of two diseases in one person can be estimated by 
multiplying the prevalences of the separate diseases. The observed comorbidity of the 
five diseases under study is significantly higher. Having a chronic disease apparently 
means being at higher risk to have a second or even third disease. 
By including only diagnoses meeting diagnostic criteria and by disregarding false 
negative diagnoses we probably underestimate also the extent of comorbidity. More-
over, these figures are related only to the 5 chronic conditions under study. The rate of 
comorbidity would have been even larger, if additional diseases, like malignant 
neoplasms, epilepsy and other neurological diseases, stroke, peripheral vascular disease, 
peptic ulcer disease, had been considered. On the other hand, by estimating the extent 
of comorbidity in a general practice setting bias due to the Berkson's fallacy cannot be 
excluded: patients under care for a chronic disease are at higher risk for detection of 
diseases than persons who do not receive such care. 
Comorbidity is partly the result of a common pathophysiological process or of 
complications in the natural course of a disease, as is the case for diabetes mellitus and 
cardiovascular disease [16]. In other cases, comorbidity of chronic diseases is accidental 
and cannot be explained pathophysiologically. 
4.5. Consequences 
Persons suffer from more than one chronic disease more frequently than could be 
expected by chance from the prevalence of the disease in the general population. This is 
a clinical reality of medical practice with consequences for research and for the 
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Organization of daily саге. 
Research 
Optimal patient care should ideally be based on valid results from clinical trials. In 
intervention studies, however, patients with comorbidity often are excluded in the 
selection of a study group, e.g. in the well-known therapeutic trials in hypertension 
[17,18]. This selection restricts the external validity of the results for excluded patient 
categories, as has recently been described for the elderly and women [19,20]. The 
existence of a second disease complicates the choice of the antihypertensive treatment 
that is proven to be effective in single disease patients (e.g. diuretics in diabetes, beta-
blockers in lung disease). Strictly speaking, these studies have not proven the effective­
ness of antihypertensive treatment in lowering blood pressure and decreasing 
cardiovascular morbidity and mortality for patients with comorbidity. In intervention 
studies on treatment of chronic diseases patients with comorbidity should be included. 
In analyzing the data patients with comorbidity can be handled as a subgroup, or 
adjustment of the results for comorbidity can be carried out 
The specific combinations of chronic diseases need further exploration, in order to 
gain more insight into patterns of disease clustering and hypothetically common 
etiology. 
Care 
Systematic surveillance of patients with chronic diseases is essential in order to 
provide them with optimal care [7]. Patients with more than one chronic disease are at 
risk of being included in more than one surveillance scheme. This should be recognized 
when designing surveillance programs, since it would be counter-productive to have 
patients visit the practice on various different occasions, as a result of following 
different schemes for each of their diseases. Careful registration of all diseases is 
conditional not only for organizational reasons but also for the care to be provided. 
Chronic diseases are regarded as "the very stuff of general practice" [6]. Proper 
management of patients with comorbidity of chronic diseases presents a real challenge 
to the GP. 
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5. Influence of comorbidity of chronic diseases on 
workload 
A study of patients with chronic diseases in general practice 
... Medical science and medical education should 
be inspired by diseases of general practice ...* 
Abstract - Consultation rates and incidence rates of intercurrent morbidity were studied in 
general practice in five cohorts of patients with common chronic diseases: hypertension, 
chronic ischemic heart disease, diabetes mellitus, chronic respiratory disease, and 
osteoarthritis. In 7 practices with 15 general practitioners the records of aü patients were 
screened for inclusion in the study. Data used for analysis are from 962 patients, whose 
diagnoses were made in agreement with diagnostic criteria, who were not under specialùt 
care, and who were followed up for 21 months. A distinction was made between patients 
with one or two or more of the five studied chronic diseases. For the single-disease 
subgroups of hypertensive patients and of diabetics two reference groups of persons without 
a chronic disease, standardized for age and sex, were composed from the population in the 
same practices. Consultation rates tended to be higher f or patients with comorbidity than for 
single-disease patients. Patients in the reference groups tended to have lower consultation 
rates than the comparable single-disease groups. Intercurrent diseases were presented more 
frequently to the general practitioner by patients with comorbidity than single-disease 
patients. Patients with onfy hypertension had lower total incidence rates of intercurrent 
morbidity than their comparable reference group. Most intercurrent morbidity consisted of 
acute common diseases as myalgia, upper respiratory tract infection and urinary tract 
infection. Patients with only hypertension or only diabetes had higher consultation rates but 
had no higher total incidence rates of intercurrent morbidity which L· in contrast to the so-
called Berkson's fallacy. 
Вита JT. De huisarts en zijn patient. Amsterdam: Allert de Lange Universiteitspers, 
1950. 
ScheUevis FG, Lisdonk EH vd, Velden J vd, Hoogbergen SHJL, Eijk JThM v, Weel С ν. 
The influence of comorbidity of chronic diseases on workload. A study of patients with 
chronic diseases in general practice [Submitted]. 
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5.1. Introduction 
ID the Netherlands chronic diseases are primarily managed by general practitioners 
(GPs). This care includes the diagnostic and therapeutic activities in the initial phase as 
well as the long term management of the disease [1]. It is expected that GPs will have 
to care for more patients with chronic diseases in the near future. This is the conse-
quence of an increase in the number of elderly people and of political measures empha-
sizing primary care. Insight into the workload generated by the care of patients with 
chronic diseases, is relevant for the management of chronic diseases in general and for 
the organisation of general practice in the future. 
This study analyses the consultation rates and the number and nature of 
intercurrent morbidity presented to the GP by five cohorts of patients with the 
following, most common chronic diseases: hypertension, chronic ischemic heart disease, 
diabetes mellitus, chronic respiratory disease, and osteoarthritis. In a previous study we 
found a considerable number of patients with combinations of two or more of these five 
chronic diseases, which is referred to as 'comorbidity' [2]. Therefore, the influence of 
comorbidity on consultation rates and intercurrent morbidity justifies special attention. 
In this study the following questions are dealt with: 
* What are the differences in consultation rates between patients with a single chronic 
disease and patients with comorbidity of chronic diseases? 
* What are the incidence and nature of intercurrent morbidity in these patient 
groups? 
5.2. Methods 
Design 
Five cohorts of patients were followed for 21 months. Intercurrent morbidity of 
patients with chronic diseases is potentially influenced by the phenomenon described by 
Berkson [3], indicating a higher chance of diagnosing diseases in patients who are 
already under care than in patients who do not consult their GP. For this reason 
reference groups of persons without a chronic disease were included in the analysis. 
Selection of practices and patients 
Study cohorts 
The selection of practices and patients has previously been described in detail [4]. 
In summary, seven practices (15 GPs) were selected following their participation in the 
Dutch National Survey of General Practice [5]. The total practice population consisted 
of 23,534 persons at the start of the study. The GPs identified all patients in their 
practices, known to have at least one of the following diseases: 
hypertension 
- chronic ischemic heart disease (CEHD) 
diabetes mellitus 
chronic respiratory disease (asthma, chronic bronchitis, emphysema) 
osteoarthritis of knee and/or hip. 
This identification procedure resulted in a total number of 1989 patients. Background 
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data were collected foi each patient and each chronic disease on the diagnostic 
procedures performed in diagnosing the chronic disease, the date of the diagnosis, and 
the physician responsible for the follow-up care. Five cohorts for the above mentioned 
chronic diseases were defined on the basis of the following three criteria: 
diagnosis made before 1 January 1988 (the start of the study period) 
diagnosis in agreement with the diagnostic inclusion criteria of the ICHPPC-2-
Defined [6] 
the patient is not receiving follow-up care for the chronic disease from a specialist 
at the start of the study. 
The last requirement ensured that all morbidity during the study period was presented 
to the GP, because in The Netherlands medical specialists can only be consulted after 
referral by a GP. Application of these criteria left a total number of 962 patients who 
were included in the analysis. Table 5.1 presents characteristics of these patients. 
Table 5.1. Background characteristics of patient cohorts 
N of patients 
males {%) 
mean age (yrs) 
single-disease (%) 
Hyper-
tension 
549 
35 
60 
86 
Chronic ischaemic 
heart disease 
183 
62 
67 
74 
Diabetes 
Mellitus 
119 
42 
65 
69 
Chronic 
respiratory 
disease 
243 
60 
45 
89 
Osteo-
arthritis 
80 
33 
69 
69 
Within the defined cohorts there were patients known to have only one disease and 
patients known with comorbidity at the start of the study. Comorbidity is defined as the 
"point-prevalent concurrence of two or more of the five studied chronic diseases" [2]. 
On this basis each cohort was divided in a single-disease and a comorbidity subgroup. 
Reference groups 
Two separate reference groups of persons without a chronic disease were composed 
for the single-disease subgroups of the hypertension cohort and the diabetes cohort. 
Hypertension and diabetes were chosen because in The Netherlands these patients are 
usually included in a surveillance scheme for regular control visits, thus allowing to 
subtract the usual number of control visits per year from the consultation rates in order 
to get figures that can be compared with the reference groups. The reference groups 
were recruited from the population of the same practices. Data used for composing the 
reference groups originated from the Dutch National Survey of General Practice. 
Persons with any of the following diseases were excluded: hypertension, diabetes 
mellitus, chronic ischemic heart disease, chronic respiratory disease (asthma, chronic 
bronchitis, emphysema), non-vertebral osteoarthritis, stroke, peripheral arterial disease, 
rheumatoid arthritis, any malignant neoplasm, and dementia. The reference groups 
were standardized for age and sex relative to either the single-disease hypertension 
subgroup or the single-disease diabetes subgroup. The reference group for the hyper-
tension subgroup consisted of 14,623 persons, the diabetes reference group of 15,847 
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persons. 
Measurements 
Study cohorts 
During the study period all consultations were registered by the GPs on special 
research forms. For each consultation the GP registered one or more diagnoses at the 
most appropriate highest diagnostic level [7]. These diagnoses were coded by trained 
clerks according to the International Classification of Primary Care (ICPC) [8]. In case 
of more than one consultation for the same diagnosis, the consultations were clustered 
by the same clerks into episodes of disease ("a problem or illness in a patient, over the 
entire period of time from its onset to its resolution" [9]). The episode diagnosis was 
characterised by the diagnosis of the last registered consultation during the episode, as 
is usual in general practice morbidity studies [10,11]. Whether the episode was 'new* 
(never presented before) or 'old' (already existing at the start of the study period) was 
indicated on the research form at the first consultation for each episode. For this paper 
only episodes of disease were included that had started during the study period, while 
episodes in progress at the start of the study were ignored. 
Reference groups 
Data on consultations and intercurrent morbidity of the reference groups originated 
from the Dutch National Survey of General Practice. The data of the reference groups 
were collected during the three months preceding the data collection in the study 
cohorts. Measurement of the number of consultations and construction of disease 
episodes was carried out identically as described for the study cohorts. 
Measures 
The number of consultations and the number of disease episodes were all rescaled 
to rates per annum. The consultation rate reflects the total number of consultations 
(face-to-face contact with the GP at the practice or at home) per year, irrespective of 
the presented morbidity. Consultation rates are presented as means for the single-
disease subgroup and for the comorbidity subgroup of each cohort Intercurrent 
morbidity reflects episodes of new diseases presented to the GP. Intercurrent morbidity 
is represented as total incidence rates per 1000 patients per year. Intercurrent morbidity 
was also studied at the level of ICPC-chapter and at the level of diagnoses. 
Reliability and validity of data on the study cohorts 
In one practice (2 GPs) the registration was interrupted for 3 months due to 
reorganization of the practice. Correction for this interruption was made in the 
calculation of the consultation rates and the incidence rates for each cohort 
The completeness of the registered number of consultations was checked by 
comparing all consultations in a sample of 2% of the patients with the regularly used 
patient charts. Of all consultations mentioned on the charts 70% appeared to be 
present in our database. This underreporting mainly consisted of consultations for 
repeat prescriptions and consultations during evenings and weekends. No correction was 
made for this underreporting. 
Agreement on the diagnostic labelling of diseases by the 15 GPs was studied by 
making a diagnosis in 30 written case histories. The mean inter-observer agreement was 
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Analysis 
Univariate descriptive analysis was carried out to compute consultation rates and 
total incidence rates for the different subgroups and the reference groups. Confidence 
intervals of the means are presented at the 95% level. Data analysis was performed 
with SPSS-X / SPSS-PC 
5.3 Results 
Consultation rates 
Table 5.2 shows the consultation rates for the single-disease and for the comorbidity 
subgroups of each disease cohort The consultation rates tended to be higher in all 
comorbidity subgroups than in the single-disease subgroups. The largest differences 
were found in patients with chronic respiratory disease, and those with osteoarthritis, 
where the consultation rates in the comorbidity subgroups were 51% and 52% higher, 
respectively, than in the single-disease subgroups. However, the comorbidity subgroups 
in these cohorts were both small (N=27, N=25, respectively). The confidence intervals 
were large for all estimated means, indicating high individual variation in consultation 
rates. Patients in the reference groups without a chronic disease had a mean consulta-
tion rate of 3.0 and 2.8, while the single-disease hypertensive and single-disease diabetic 
patients showed rates of 4.7 and 5.7, respectively. In The Netherlands hypertensive and 
diabetic patients usually visit their GP two to four times a year for control of their 
chronic disease. 
Table 5.2. Consultation rates in five disease cohorts (means and 93% confidence intervals) for single-
disease, comorbidity, and reference group 
Single-disease Reference Comorbidity 
mean (95% CI) mean (95% CI) mean (95% CI) 
Hypertension 4.73 (4.43-5.04) 2.97 (2.88-3.06) 5.44 (4.30-6.58) 
Chronic ischemic 
heart disease 5.46 (4.67-6.24) 6.04 (4.78-7.30) 
Diabetes mellitus 5.66 (4.91-6.42) 2.81 (2.73-2.89) 6.54 (4.65-8.44) 
Chronic respiratory 
disease 4.90 (4.27-5.53) 7.40 (5.01-9.80) 
Osteoarthritis 4.24 (3.23-5.24) 6.43 (4.90-7.96) 
Intercurrent morbidity 
Total incidence rates of intercurrent morbidity for the subgroups of the five cohorts 
are listed in Table 5.3. In all cohorts patients with comorbidity tended to have higher 
total incidence rates of intercurrent morbidity than the corresponding single-disease 
patients, varying from 8% for diabetics to 74% for osteoarthritis patients. 
Surpisingry, in case of the hypertensive patients, the total incidence rate for the 
55 
Hypertension 
Chronic ischemic 
heart disease 
Diabetes mellitus 
Chronic respiratory 
disease 
Osteoarthritis 
Single-disease 
1247 
1794 
1618 
1784 
1504 
reference group was 42% higher than for the corresponding single-disease group. Tbe 
difference between the total incidence'rates of the single-disease diabetics and their 
reference group without a chronic disease is unimportant 
Table 53. Intercurrent morbidity in five disease cohorts for single-disease, comorbidity, and reference 
groups (total incidence rates per 1000 patients per year) 
Reference Comorbidity 
1776 1645 
2021 
1683 1755 
2489 
2619 
Analysis of the incidence rates of intercurrent morbidity at the level of ICPC-
chapter showed that the highest rates were found in the chapters К (circulatory), L 
(musculoskeletal), R (respiratory), and U (urology). No important differences in this 
pattern were found between the subgroups within each of the five cohorts (data not 
shown). At the level of diagnoses the five diseases with the highest incidence rates were 
determined for each single-disease subgroup. Only eight acute diseases appeared with 
remarkable similarity in all five cohorts: myalgia, upper respiratory tract infection, 
acute bronchitis, urinary tract infection, influenza, ear wax, pneumonia, and sinusitis. 
Comparison between the single-disease and comorbidity subgroups showed a trend of 
higher incidence rates in the comorbidity subgroups of hypertensive patients, of diabetic 
patients, and of C1HD patients. The reference groups showed clearly lower incidence 
rates of these acute diseases than the corresponding single-disease subgroups (data not 
shown). 
5.4. Discussion 
Consultation rates 
The mean consultation rate for all patients in general practice in the Netherlands is 
3.2 [12]. The mean consultation rate of patients with a single chronic disease in this 
study varied from 4.2 to 5.7; for patients with more than one of these diseases it varied 
from 5.4 to 7.4. Correction for the 30% underreported consultations would further 
increase these rates. Having more than one of the studied chronic diseases apparently 
implies more consultations per year than having only one. The consultation rates do not 
increase linearly with the number of chronic diseases. The rates in the two reference 
groups were lower than the corresponding single-disease hypertension and diabetes 
subgroups. Having only hypertension or only diabetes induces higher consultation rates 
than usual for this age group. Assuming that patients with hypertension and diabetes 
usually visit their GP two to four times a year for regular control of their chronic 
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disease, the number of consultations for other reasons seems to be lower compared to 
patients without a chronic disease. This finding confirms previous results in hypertensive 
patients [13]. Patients with only hypertension or only diabetes probably present their 
other problems partially during their control visits. Our results only indicate trends of 
consultation rates, since the confidence intervals of the means between subgroups show 
considerable overlap. 
Intercurrent morbidity 
Another morbidity study in the entire population of four general practices found a 
total incidence rate of 1681 per 1000 patient years [10]. The figures of the single-disease 
subgroups and the reference groups in this study are of a corresponding magnitude. The 
total incidence rates of intercurrent morbidity were lower in the single-disease sub-
groups than in the comorbidity subgroups. In diabetics the presence of other chronic 
diseases seemed to have little influence on total incidence rates. The difference between 
the subgroups was substantial in the cohorts of patients with chronic respiratory disease, 
and of patients with osteoarthritis: in these patients the presence of other chronic 
diseases seemed to have an increasing influence on intercurrent morbidity. 
Our results confirm an earlier finding that patients with chronic diseases also 
present 'common diseases' to the GP [14]. It could be argued that patients with chronic 
diseases would save their problems until the next control visit This would lead to 
increased morbidity without increased consultation rates in patients with chronic 
diseases compared to those without chronic diseases, according to the phenomenon 
described by Berkson [3]. When we compare intercurrent morbidity incidence and 
consultation rates for hypertensive patients with the corresponding reference group, we 
found the reverse effect. Patients with only hypertension or only diabetes, although they 
consult their GP more frequently, do not present more intercurrent morbidity than 
persons of the same age without either disease. On the contrary, patients without a 
chronic disease have even higher rates of total intercurrent morbidity. 
It can be expected that patients will particularly more often need care of their GP 
in the period of terminal illness. However, the number of patients in this study who 
died during the observation period (N= 17) was too small to analyze this. 
Limitations 
The incompleteness of the database of the study group, reflecting 70% of the 
consultations listed on the patients' charts could not be resolved in a satisfactory way. 
The fact that the participating GPs had to complete research forms for consultations of 
only a part of their patients made it difficult for them to do so in all cases. The 
incompleteness causes an underestimation of the consultation rates. Correction for 
underestimation by just adding 30% in all groups would ignore possible differences 
between subgroups with regards to the completeness of their data. Therefore, we have 
presented the observed figures without correction. This seems to be warranted for two 
reasons. First, many of the missed consultations were for the purpose of obtaining a 
repeat prescription. Secondly, we have analyzed intercurrent morbidity at the level of 
episodes of disease, which decreases the importance of a missed consultation. 
In interpreting the results it should be kept in mind that there is an overlap of the 
comorbidity subgroups from the different cohorts: patients with more than one chronic 
disease are present in more than one comorbidity subgroup. 
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Comorbidity is defined here as a combination of two or more of five studied 
chronic diseases. It depends on the definition of chronicity what proportion of all 
chronic diseases in a general, practice population is represented by the five studied 
diseases. When the summated prevalence of the diseases used for exclusion in the 
composition of the reference groups is taken as 100%, the five studied chronic diseases 
represent about 70% of these. Including other chronic diseases, like gastrointestinal and 
mental health problems, would of course change the obtained results. 
5.5. Conclusion 
Patients with chronic diseases have high consultation rates which are even higher 
when these patients have more than one chronic disease. However, patients with only 
hypertension or only diabetes do not have high total incidence rates of intercurrent 
morbidity, suggesting that the Berkson's fallacy plays only a minor role in the figures of 
these patients. Patients with chronic diseases present also common diseases to the GP. 
This emphasizes the important role of GPs in the management of all diseases in a 
single patient 
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6. Performance of general practitioners in the follow-up 
care of patients with chronic diseases 
The implementation of consensus guidelines 
... Writing guidelines is easier Лап making them work ..." 
Abstract - The objective of this study was to evaluate the effects of formulating and imple­
menting consensus guidelines on the follow-up care for patients with chronic diseases by 
general practitioners. Agreement was studied between guidelines reflecting optimal care and 
the actually delivered care by 15 general practitioners to their patients with hypertension 
(N=613), chronic ischaemic heart disease .(N=76), diabetes mellitus (N=95), chronic 
respiratory disease (N=115), and osteoarthritis of hip and/or knee (N=17). The partici­
pating general practitioners held monthly meetings to reach consensus on guidelines for 
optimal care. The general practitioners registered data on the care delivered to their patients 
during 21 months. The implementation of the consensus guidelines was supported by feed­
ing back information on actually delivered care integrated in peer review meetings. Perform­
ance measures reflecting the extent of agreement between guidelines and actually delivered 
care were defined on the basis of items of the guidelines. An overall performance measure 
was computed Additionally, an inventory was made of problems occurring during the 
implementation of the guidelines. The performance of general practitioners never reached 
full agreement with the consensus guidelines and it differed between the various perform­
ance measures, between the diseases, and between the general practitioners. There is an 
overall slightly positive trend during the 21-month period, which is reflected in an increase 
of the performance measure and/or a decrease in the variation between the general 
practitioners. Increase was particularly noticeable in actions that were to be carried out rou­
tinely in the care of patients with hypertension and diabetes mellitus. There was no indi­
cation that agreement between guidelines and actual performance was an overall general 
practitioner characteristic rather than specific for a single disease. Problems mentioned by 
the general practitioners as underlying cause for discrepancies between guidelines and 
performance often concerned organizational matters. Peer dùcussions led to practicable 
recommendations. It is suggested that guidelines with an immediate impact on the course 
and management of a disease will be followed more easily than guidelines that only 
indirectly influence the course of the disease or that aim at risk factors. 
' Haines A, Feder G Guidance on guidelines [Editorial]. Br Med J 1992;305:785-786. 
Schellevis FG, Eijk JThM v, Lisdonk EH vd, Velden J vd, Weel С v. Performance of 
general practitioners in the follow-up care of patients with chronic diseases [Submitted]. 
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6.1. Introduction 
Formulating guidelines for optimal care by general practitioners (GPs) is an important 
step in the process of improving quality of care. Experts do not agree upon whether 
local or regional groups of GPs should formulate their own guidelines, or central 
national organizations should perform this task [1-6]. In a recent publication the 
development of guidelines on various levels (central, local, practice, and individual) was 
recommended [7]. In The Netherlands central development of guidelines started in 
1982 with consensus meetings on controversial issues in specialist care by the 'Centraal 
Begeleidingsorgaan voor de Intercollegiale Toetsing'. Guidelines ('standards') for 
optimal GP care are being centrally developed since 1989 by the Dutch College of 
General Practitioners. In the U.K. the regional model has been adopted [3,4]. 
The process of formulating guidelines and their implementation in daily practice has 
so far mostly been evaluated indirectly by interviews with physicians, or by using data 
on a highly aggregated national level [7-10], rather than directly on the level of 
individual doctors and their patients [4,11]. 
This paper reports the evaluation of the implementation of regionally developed 
guidelines for the follow-up GP care of their patients witch chronic diseases. It is part 
of a study on the prevalence of chronic morbidity in general practice and on the care 
delivered to these patients. This project preceded the development of standards by the 
Dutch College of General Practitioners and the publication of the first standard [12] in 
anticipation of the increasing number of patients with these diseases in the near future. 
The implementation of these guidelines in daily practice is evaluated in this article on 
the following two points: 
* whether the actual care of GPs delivered during the follow-up of patients with chro-
nic diseases tends to conform more to consensus guidelines for optimal care in the 
course of time and what the variation is between GPs and between diseases; 
* problems arising during the implementation of these guidelines in dairy practice and 
how these problems are dealt with. 
6.2. Methods 
Design 
An intervention study was carried out during a period of 21 months consisting of 
three elements: development of guidelines for optimal care, implementation of the 
guidelines and continuous registration of actually delivered care with follow-up 
measurements. 
Selection of GPs 
The selection of practices and GPs has previously been described in detail [13]. In 
summary, 7 practices (15 GP's) were selected by convenience following their participa-
tion in the Dutch National Survey of general practice [14]. The practices were located 
in the south-east part of the country. The total list size of the practices at the start of 
the study amounted to 23,534 persons. Two practices were single-handed, four had two 
GPs and one was a group practice with 5 GPs. Each GP had an own practice list. Three 
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practices were involved in vocational training for general practice, the others had no 
special relationship with a university department of general practice. 
Selection of patients 
Previously, we have described how the GP's identified the patients with at least one 
of five, most common chronic diseases [13]. For this paper only patients diagnosed 
before the start of the study and with a complete follow-up under GP care after the 
start were selected: 613 with hypertension, 95 with diabetes mellitus, 76 with chronic 
ischaemic heart disease (CIHD), 115 with chronic respiratory disease, and 17 with 
osteoarthritis of hip and/or knee. 
Intervention 
Formulation of guidelines 
Monthly meetings (except in July and in August) of 60-90 minutes were held with 
the participating GPs during the entire study period of 21 months, starting in January 
1988. These meetings were held in two, sometimes three subgroups. Attendance of all 
participating GPs was requested. When this was impossible, attendance of at least one 
representative per practice was urged. The first seven meetings in each subgroup of 
GPs were aimed at formulating consensus guidelines of optimal follow-up care for each 
of the five chronic diseases mentioned above. A summary of the 'state of the art' fol-
low-up care and a draft version of proposed guidelines, both produced by the first 
author, were sent to the participants one week before each meeting. All subgroups 
received the same material. During the meeting the proposed guidelines were discussed 
and amended. A written report was prepared of each meeting and discussed and 
accepted in the next meeting. The presence of the first author at each meeting gua-
ranteed that differences between the subgroups were discussed and that finally identical 
guidelines were adopted unanimously. Table 6.1'(left column) lists the items of these 
guidelines for each of the five chronic diseases. All participating GPs explicitly stated 
their intention to act according to these guidelines and to motivate discrepancies 
between the guidelines and the actually delivered care. 
Implementation of guidelines 
During the subsequent meetings the participating GPs received written individual 
feedback on their actually delivered care. This information was derived from the data 
registered by the GPs (see further). In each meeting discrepancies between the 
guidelines and the actual follow-up care for each disease category were discussed using 
the method of peer review [15]. When discrepancies between the guidelines and the 
actually delivered care were noted, the GPs were asked what hindered the implementa-
tion of the guidelines. Depending on the nature of these problems solutions were 
sought by clarifying possible resistance against change, by lowering thresholds for chang-
ing routines by means of practicable suggestion, or by peer discussion. Again, a written 
report was made of these meetings, mailed to the participants, discussed and approved 
at the next meeting. 
Registration 
Data on actually delivered care were recorded on special forms by the GPs during 
all consultations with patients during the entire study period. These data included: 
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diagnosis made during consultation coded according to the International Classifica­
tion of Primaiy Care (ICPC) [16]; 
performance of each of the following procedures (Yes/No): physical examination, 
blood pressure reading, measurement of body weight, blood glucose, serum 
creatinine, urine albumin excretion, ophthalmologic examination (fundoscopy by 
the GP or referral to the ophthalmologist), influenza vaccination; 
making a follow-up appointment, defined in a term in weeks or months or by a 
specific date (Yes/No). 
Performance measures 
For each of the five chronic diseases performance measures were defined, reflecting 
the extent of agreement of actual performance with performance according to the 
guidelines for each disease (Table 6.1). The performance measures were computed at 
first on the patient level and then aggregated to the GP level. 
Agreement between performance and guidelines might be an overall GP character­
istic rather than be specific for a single disease. This was explored by computing an 
additional overall measure of agreement per GP. For this purpose the number of 
diseases for which their performance was rated in the highest tertile class was counted. 
This overall performance measure reflects the performance of a GP in relation to the 
performance of the other participating GPs, rather than the degree to which the overall 
performance of a GP conforms to the guidelines. 
Data on problems encountered during the implementation of the guidelines and 
how these problems were resolved, were derived from the detailed reports of the 
meetings. These data were interpreted and classified afterwards according to the fol­
lowing categories: 
problems involving organization of the practice; 
problems of motivation; 
lack of specific skill or experience; 
resistance against standardization. 
Table 6.1. Guidelines on and measures of performance of general practitioners in the management of five 
chronic diseases 
Guidelines Performance measures 
Hypertension ν 
* blood pressure measuring at 
each control visit 
* urine albumin measurement 
once a year 
* follow-up appointment 
after each control visit 
percentage control visits in 
which blood pressure was 
measured 
percentage of hypertensive 
patients whose urine albumin was 
measured during the study period 
percentage control visits fin­
ished by a follow-up 
appointment 
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Table 6.1. (continued) Guidelines on and measures of performance of general practitioners in the 
management of five chronic diseases 
Guidelines Performance measures 
Diabetes mellitus 
* taking recent history 
of signs and symptoms 
related to diabetes mellitus 
* blood glucose measurement 
at each control visit 
* body weight measurement at 
each control visit 
* blood pressure measuring once 
a year 
* influenza vaccination once 
a year 
* serum creatinine measurement 
every three years 
* ophthalmologics! examination 
every three years 
Chronic ischemic heart disease (CIHD) 
* taking recent history of 
signs and symptoms due to CIHD 
* in case of hypertension: 
blood pressure measurement at 
each control visit 
* in case of obesity: 
body weight measurement 
at each control visit 
Chronic respiratory disease (CRD) 
* taking recent history of 
signs and symptoms due to CRD 
* lung examination at. 
each control visit 
* influenza vaccination once 
a year 
Osteoarthritis hip/knee 
* taking recent history of 
signs and symptoms due to 
osteoarthritis 
* joint examination at 
each control visit 
percentage control visits in 
which blood glucose was measured 
percentage control visits in 
which body weight was measured 
percentage of diabetic patients 
whose blood pressure was 
measured during the study period 
percentage diabetic patients who 
were vaccinated against influ-
enza during the study period 
percentage diabetic patients 
whose serum creatinine was 
measured during the study period 
percentage diabetic patients who 
underwent ophthalmologics! 
examination during the study 
period 
percentage CIHD control visits 
in patients with hypertension in 
which blood pressure was measured 
percentage CIHD control visits 
in obese patients in which body 
weight was measured 
percentage control visits in 
which lungs were examined 
percentage CRD patients who were 
vaccinated against influenza each year 
percentage control visits in 
which joint examination took 
place 
Analysis 
The entire study period was divided in periods. For patients with diabetes five 4-
months periods and for the others three 6-months periods were distinguished according 
to the guidelines on the frequency of follow-up visits. The performance measures for 
each disease are presented as medians of the separate follow-up measurements. 
Interdoctor variation was expressed by the interval between the first and second tertile 
value. The overall performance measure reflects the frequency per GP of a score in the 
highest tertile class in the performance in five diseases (range 0-5). Analyses were 
carried out with SPSS-X and SPSS-PC. 
6.3. Results 
.The mean attendance rate of the individual GPs at the meetings was 68%. When 
computed on the practice level (attendance of at least one GP per practice) the mean 
attendance rate was 79%. 
Performance measures 
Hypertension 
Table 6.2 lists the performance measures of the GPs for the follow-up care of 
patients with hypertension. The GPs conformed increasingly to the guidelines during 
the study period with a decrease in variation between GPs on the following aspects of 
care: measuring blood pressure, and making an appointment. This was reflected in a 
narrowing of the range between the 33-67 percentiles and in the results on the level of 
individual GPs: 5 GPs had a maximal score on both performance measures in the first 
period and these remained maximal, measuring blood pressure increased at least 10% 
in 6 GPs, and making a follow-up appointment increased at least 10% in 5 GPs. 
Measurement of albuminuria was rarely performed during the study period (data not 
shown): once for 60 of the 613 patients and twice or more for eight patients, never in 
the remaining patients. 
Table 62. Performance measures of general practitioners (N=15) in patients with hypertension. Median 
percentages (33- and 67-percentiles) per 6-month period 
Mean number of patients per GP: 40.9 (range 1-111) 
Measuring Making 
blood pressure appointment 
(33-67 (33-67 
Period % percentiles) % percentiles) 
1 90.2 (84.7- 97.0) 83.5 (72.2- 95.7) 
2 98.9 (97.1-100.0) 92.6 (90.9- 99.3) 
3 99.6 (98.2-100.0) 923 (85.1-100.0) 
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Chronic ischemie heart disease (CIHD) 
The performance measures regard only 41 of the 66 CEHD-patients, namely those 
with hypertension (N=17) and those with obesity (N=2A). No clear trend was detect-
able in measuring blood pressure in hypertensive CIHD patients (mean percentages in 
period 1, 2 and 3: 100, 75, 80% of the visiting patients) and in measuring body weight 
in obese patients (27%, 60%, and 50% of the visiting patients, respectively). Aggrega-
tion on the GP level resulted in too small, and therefore unreliable, figures. 
Diabetes mellitus 
Table 6.3 shows the performance of the GPs for patients with diabetes mellitus. The 
fraction of control visits in which blood glucose was measured increased steadily from 
75% to 90% with a decrease in the range between the 33-67 percentiles. The change in 
performance measures of individual GPs varied: 2 GPs had a maximal score in the first 
period which remained stable, and 5 GPs showed an increase of at least 10% between 
the first and the last period. The performance measures of the others remained stable 
at a lower level or decreased. Measuring body weight was less frequently performed and 
the increase was marginal: the measure of 2 GPs increased, of another 2 GPs 
decreased, and the others remained stable. All GPs but one measured the blood pres-
sure of their diabetic patients twice or more during the study period. Only three GPs 
vaccinated all their diabetic patients against influenza. Serum creatinine was measured 
during the study period at least once in 24% of the diabetic patients. When extrapo-
lated to three years (according to the guidelines), two GPs would be fully compliant in 
the measurement of serum creatinine of all their diabetic patients once in three years. 
Ophthalmological examinations were carried out in 26% of the patients at least once 
during 21 months. One GP would reach an extrapolated measure of 100% of his dia-
betics undergoing an ophthalmological examination in three years. 
Table 63. Performance measures of general practitioners (N=15) in patients with diabetes mellitus. 
Median percentages (33- and 67-percentiles) per 4-month period 
Mean number of patients per GP: 63 (range 1-16) 
Measuring Measuring 
glucose body weight 
(33-67 (33-67 
Period ' % percentiles) % percentiles) 
1 76.5 (66.7-81.0) 50.5 (31.8-52.8) 
2 82.1 (68.8-85.7) 52.1 (30.0-54.2) 
3 85.7 (78.6-87.5) 64.3 (35.0-66.7) 
4 83.3 (77.1-833) 44.4 (12.5-47.2) 
5 89.6 (80.0-91.8) 55.0 (25.8-563) 
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Chronic respiratory disease (CRD) 
Compliance with the guidelines regarding hing examination remained stable 
between 80 and 85% during the study period (Table 6.4) with a decrease of the inter-
physician variation: 5 GPs remained on their maximum score, and 4 GPs showed an 
increase of at least 10%. Of the 115 patients 31% were vaccinated against influenza; the 
vaccination rate per GP ranged from 0 to 60% of the CRD patients. 
Table 6.4. Performance measures of genera] practitioners (N=15) in patients with chronic respiratory 
disease. Median percentages (33- and 67-perceotiles) per 6-month period 
Mean number of patients per GP: 7.7 (range 1-22) 
Lung anamination 
Period % (33-67 percentiles) 
1 92.1 (72.7-100.0) 
2 98.6 (75.0-100.0) 
3 93.8 (80.0- 95.4) 
Osteoarthritis 
The agreement of GP performance with the guidelines on the follow-up of 
osteoarthritis patients, expressed in the fraction of control visits in which joints were 
examined, decreased during the study period from 72 to 59% (data not shown). These 
figures are based, however, on limited numbers of patients and control visits. Therefore, 
aggregation to GP level has not been executed. 
Overall measure 
The performance of one GP was in the highest percentile of measures for all five 
diseases (Table 6.5). Three GPs scored below the highest percentile for all five diseases. 
Table 65. Overall performance of general practitioners (Af=15) in patients with chronic diseases: 
frequency of performance score in highest percentile group (range 0-5) 
Number of 
Score general practitioners 
0 3 
1 2 
2 7 
3 2 
4 
5 1 
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Problems experienced In Implementation 
The discrepancies between actual performance and guidelines often concerned 
actions that were to be carried out only intermittently, e.g. once a year, rather than 
routinely during each follow-up visit The GPs recognized that it was difficult to imple-
ment such a routine in practice. Different solutions were proposed and adopted, e.g. 
reservation of consultation hours for specific patient groups, or administration by the 
practice assistant In general, during the study period all GPs delegated - to a different 
extent - tasks regarding the follow-up care to the practice assistant, especially for 
patients with hypertension and diabetes mellitus, assuming that practice assistants would 
act with more discipline. Making appointments for follow-up visits was increasingly 
supported by using appointment cards handed out to patients. 
The GPs ascribed the interdoctor variation on the performance of intermittent 
actions to some extent to 'hobbies': high motivation for specific interventions: some GPs 
were focused on the infhienza-vacoination of all patients-at-risk, others were more inter-
ested in screening patients for ophthalmological complications, although all GPs agreed 
on the clinical relevance of these actions. 
Lack of experience with certain skills, e.g. fundoscopy or examination of joints, was 
mentioned as another cause for discrepancy between guidelines and performance. This 
led in one subgroup to a training by colleagues. 
Resistance against standardization of their performance was discovered by discuss-
ing individual cases with the GPs in which they considered the guidelines to be useless. 
Without denying the value of an individualized application of the guidelines we tried to 
impress during the meetings that inapplicability of guidelines in some cases is not a 
reason for considering them useless in general. 
6.4. Discussion 
The performance of GPs never reached full agreement with the consensus 
guidelines and it differed between the various performance measures, between the 
diseases, and between the GPs. There is an overall slightly positive trend during the 21-
months period, which is reflected in an increase of the performance measure and/or a 
decrease in the variation between the GPs. The assumption that the degree of agree-
ment between guidelines and actual performance is a general GP characteristic could 
not be confirmed. 
Many and various problems arose during the implementation. During the meetings 
animated discussions of these problems took place and many creative solutions were 
proposed. Some of these solutions were implemented in the practices,' which can be 
seen as a positive outcome. 
It could be objected that the effects measured in this study can only be validly 
ascribed to the intervention if a control group of GPs and/or a control period before 
intervention would have been included. However, it was reasoned that neither approach 
would have provided a valid control. A control group of GPs would have consisted of 
physicians who continued to deliver their usual care during the same period without the 
influence of attending educational programs, reading publications or discussing 
problems with colleagues on these subjects. This would have created an artificial envi-
ronment, which does not represent daily general practice anymore. A control group as 
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well as а "before and after' design would have included registration of actions during 
consultations on detailed research forms, without influencing the nature of delivered 
care. Such registration would undoubtedly have evoked the performance of actions 
mentioned on the forms, and thus the control group or control period would not have 
represented the usual care situation. The alternative of collecting information on 
delivered care from the patients' records would have been unsatisfactory because these 
are usually restricted to outcome measures relevant for the follow-up of the patients. 
Some performance measures showed an increase during the study period, others did 
not show a clear change. Those that increased reflect actions which had to be carried 
out routinely and had immediate impact on the further management of the disease: 
measuring blood pressure in hypertensive patients and blood glucose in diabetic 
patients. Those that did not change during the study concerned actions that were to be 
carried out intermittently and/or had to do with risk factors with only potential influ­
ence on the disease in the future: vaccination against influenza, measurement of serum 
creatinine and ophthahnological examination. Apparently, actions with direct con­
sequences for the disease and its management are considered more important and are 
therefore performed more consistently in the course of time under the influence of the 
guidelines. This phenomenon requires more attention in research on quality of care and 
in projects on the implementation of guidelines. 
Evaluation of the process of medical care should ideally be carried out by measur­
ing performance of actions which can be considered to be related to the outcome of 
care. The value of measuring blood pressure in patients with hypertension and blood 
glucose levels in diabetic patients will not be disputed, but a meaningful performance 
measure reflecting optimal care for CIHD or osteoarthritis patients is not available. 
The availability of a meaningful performance measure would be an additional require­
ment for adequate guidelines [7]. 
Evaluation of actual GP performance from registered data bears the risk of under-
or overestimation of the actual performance. A deficient registration regime is a 
possible source of underestimation. One could argue, however, that deficient registra­
tion represents a low quality of care [17]. Overestimation would occur if the participat­
ing GPs registered procedures which they had not actually carried out. This was not 
checked, but it seems very unlikely that this occurred during the study period, since par­
ticipation in the study was voluntary, there were no sanctions on non-compliant per­
formance, the atmosphere during the meetings was friendly, and non-compliant 
performance led to more insight in one's own work. 
In this study the actual performance of GPs was compared with the guidelines they 
had formulated themselves. This has always been a strong point in favour of the 
regional development of guidelines [7]. The guidelines which the participating GPs 
agreed upon, reflect minimal optimal care compared to the 'standards' on diabetes 
mellitus, hypertension, and chronic respiratory disease published subsequently by the 
Dutch College of General Practitioners [12,18,19]. Thus a performance of 100% 
compliance with the guidelines would not have been unreasonable. Such full compliance 
was reached only by some GPs and for some performance items only. We have no clear 
explanation why this is so, since all GPs participated with enthusiasm until the end of 
the study. The attendance at the meetings did not decrease during the study period. It 
has been stated before that "simply feeding back information on performance has 
almost no impact on changing clinical behaviour" [20]. Feedback most probably 
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influences clinical practice in doctors who already agreed to review their practice [11]. 
In this project feedback of information was supported by peer review. More intensive 
feedback, e.g. on individual cases [21], or a longer implementation period might bring 
about more changes in performance. 
6.5. Conclusions 
This paper presents an evaluation of the implementation of guidelines for the 
follow-up care of patients with chronic diseases. In the course of time, GP performance 
tended conform more to the guidelines, but 100% agreement was only reached by some 
GPs on some performance items. Actions which had to be carried out routinely and 
which had an immediate impact on the management of the disease showed an increas­
ing agreement with the guidelines. Meaningful performance measures were not 
available for all chronic diseases. Feeding back information on actual performance inte­
grated in a peer review process resulted in practicable recommendations. 
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7. Outcome of the follow-up care of patients with chro 
nie diseases by general practitioners 
The implementation of consensus guidelines 
... Science based on sphygmomanometric readings must 
not be allowed to overrule the art of personal care ..." 
Abstract - The effect of formulating and implementing guidelines for the optimal follow-up 
care, in combination with registration of delivered care and of outcome was studied 
longitudinally in patients with chronic diseases in general practice. All patients with hyper­
tension, diabetes mellitus, chronic ischaemic heart disease, chronic respiratory disease, and 
osteoarthritis of hip and/or knee cared for by IS general practitioners were identified 
(N=906 cases) and followed over a period of 21 months. Simultaneously, the general 
practitioners developed and implemented consensus-based guidelines on the optimal follow-
up care for these patients. For each of the five diseases disease status indicators were 
defined. Patient compliance to follow-up visits and compliance of the general practitioners 
with the guidelines were the main independent variables. The disease status indicators of the 
five chronic diseases fluctuated during the study period without showing a substantial 
change. Trends were found for a relation between patient compliance and increase of 
normotensive status in hypertensive patients, and between performance of general practi­
tioners and increase of normoglycaemic status of diabetics. No indications were found for 
an overall, non-disease-related relationship between the compliance of general practitioners 
with the guidelines for care and change of disease status indicators of the patients. It is 
argued that the disease status indicators chosen for patients with chronic ischaemic heart 
disease (normal blood pressure), chronic respiratory disease (number of exacerbations) and 
osteoarthritis (number of episodes of joint related problems) do not well reflect their disease 
status. Evaluation of the implementation of guidelines requires the availability of meaningful 
outcome measures. 
Fry J. Common diseases, 4* ed. Lancaster: MTP Press, 1985. 
Schellevis FG, Eijk JThM v, Lisdonk EH vd, Velden J vd, Weel С v. Outcome of the 
follow-up care of patients with chronic diseases by general practitioners [Submitted]. 
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7.1. Introduction 
Our research project aimed at the improvement of quality of care in general practice by 
implementing guidelines on the follow-up care of patients with chronic diseases. 
Traditionally, three aspects of quality of care are considered: structure, process and 
outcome [1]. We were able to study aspects of process and outcome. This study took 
place within the framework of the Dutch National Survey of General Practice [2], which 
was aimed, among other things, at gaining insight in the care provided by general 
practitioners (GPs). In a previous paper we described the care delivered by GPs to 
patients with common chronic diseases (hypertension, chronic ischemic heart disease, 
diabetes mellitus, chronic respiratory disease, and osteoarthritis) [3]. This paper reports 
on the outcome of care. 
Outcome of care can be operationalized in different ways, e.g. morbidity, mortality, 
cost/benefit, subjective and objective health status. We have focused on indicators re-
flecting the disease status of patients with the above-mentioned chronic diseases: 
* What is the effect of the implementation of guidelines for follow-up care on the 
disease status of patients with chronic diseases in general practice? 
* What is the influence of patient characteristics and of compliance of patients and 
GPs with guidelines? 
7.2. Methods 
Design 
An intervention study was carried out during a period of 21 months, starting 1 
January 1988, which consisted of three elements: development of guidelines, implemen-
tation of guidelines, and continuous registration of actually delivered care and of 
disease status indicators of the patients. 
Selection of GPs and cases 
The selection of GPs and patients has previously been described in detail [3,4]. The 
GPs identified in their practices all patients known to have one or more of the follow-
ing diseases: 
hypertension; 
diabetes mellitus; 
- chronic ischemic heart disease (CIHD); 
chronic respiratory disease (asthma, chronic bronchitis, emphysema; CRD); 
osteoarthritis of knee and/or hip. 
For the purpose of this study the patients had to satisfy the following criteria: diagnosis 
was made before 1 January 1988, and a complete follow-up GP care during the study 
period was received. 
Intervention 
. Formulation and implementation of guidelines 
As previously described in detail [3], monthly meetings were held during the study 
period. In the first phase of the study period these meetings were aimed at formulating 
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guidelines for optimal follow-up care for each of these five chronic diseases. During the 
last 10 meetings the GPs received individual feedback on their performance as com­
pared with the guidelines. Discrepancies between guidelines and actually provided care 
were discussed by means of the peer review method. 
Registration 
During all consultations with the patients data were registered by the GPs on 
special research forms during the entire study period. These data included items with 
regard to the actually delivered care, which were used for the feedback meetings [3]. 
Additionally, data on the disease status of the patients were registered on the same 
forms. These data included morbidity presented by the patient and results of examin­
ations and laboratory tests. 
Measurements 
Patient characteristics were measured by the GPs at inclusion and are listed in 
Table 7.1. Blood pressure was measured by the GPs with a sphygmomanometer or a 
digital manometer gauged at the start of the study. Diastolic blood pressure was read at 
the disappearance of the sounds (Korotkoff phase V). Body length was measured once 
at the start of the study. Body weight was measured at each office with the same 
balance during the entire study period. Blood glucose levels were generally measured in 
the office, using blood test strips and a reflectometer, occasionally in a regional 
laboratory. 
Table 7.1. Characteristics of five patient groups with chronic diseases 
„ 
- Male (%) 
Age (mean) 
Initial BP 
(diastolic -
mean - mmHg) 
Baseline BP 
(diastolic -
mean - mmHg) 
Baseline BMI 
(mean - kg/m2) 
Baseline blood 
glucose (mean-
mmol/1) 
fasting 
non-fasting 
Comorbidity 
(%oiN) 
Hyper­
tension 
(ЛГ=613) 
31 
60 
106 
92 
28 
17 
Diabetes 
Mellitus 
(N=95) 
33 
66 
27 
83 
10.9 
51 
CTHD" 
(N=66) 
49 
69 
82 
45 
CRD 
(N=115) 
58 
49 
16 
Osteo­
arthritis 
(N=V) 
18 
65 
28 
41 
* CIHD=chronic ischemic heart disease; CRD=chronic respiratory disease; BP=blood pressure; BMI= 
body mass index 
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Diagnoses made during the consultations were coded by trained clerks according to the 
International Classification of Primary Care (ICPC) [5]. They were clustered into dis-
ease episodes ('a problem or illness in a patient over the entire period of time from its 
onset to its resolution' [6]). At the first consultation of each episode it was indicated 
whether the episode was 'new* or 'old'. 
Measures 
Disease status indicators, the dependent variables, were defined for each of the five 
studied chronic diseases and are listed in Table 7.2. For hypertension, diabetes mellitus, 
and CIHD these indicators are the same as those mentioned as targets in the 
guidelines. For CRD and osteoarthritis episodes of exacerbations, acute bronchitis for 
CRD and joint related problems for osteoarthritis, were chosen as indicators. Body 
mass index (BMI) was computed using the body weight measured during the consulta-
tions and the body length at baseline. Exacerbations of chronic respiratory disease were 
defined as new episodes of acute bronchitis (ICPC code R78). Joint related problems 
were defined as new episodes of pain in knee/hip or myalgia (ICPC codes L13, L14, 
LIS, or L18). Incidences were expressed in percentages of patients affected. 
Table 72. Dependent and independent variables used in the study per chronic disease 
Dependent variables: 
Disease status indicators 
Independent variables: 
Patient and care characteristics 
Hypertension % of patients with diastolic 
blood pressure < 95 mmHg 
sex 
age 
initial blood pressure 
' baseline blood pressure 
comorbidity 
patient compliance 
received care: agreement with 
guidelines 
Diabetes mellitus 
% of patients with 
BMI < 27 kg/m2 
% of patients with blood glucose 
fasting < 8.0 mmol/1 or 
non-fasting < 10.0 mmol/1 
% of patients with 
BMI < 27 kg/m1 
age 
baseline BMI 
patient compliance 
sex 
age 
baseline blood glucose 
comorbidity 
patient compliance 
received care: agreement with 
guidelines 
sex 
age 
baseline BMI 
comorbidity 
patient compliance 
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Table 12. Dependent and independent variables used in the study pec chronic disease (continued) 
Chronic ischemic 
heart disease 
Chronic respiratory 
disease 
Osteoarthritis 
Dependent variables: 
Disease status indicators 
% of patients with diastolic 
blood pressure < 95 mmHg 
incidence of exacerbations 
incidence of joint related 
problems 
Independent variables: 
Patient and care characteristics 
sex 
age 
baseline blood pressure 
comorbidity 
patient compliance 
sex 
age 
comorbidity 
sex 
age 
comorbidity 
Patient and care characteristics, the independent variables in this study, are also 
listed in Table 7.2. Patient characteristics, as age, and diastolic blood pressure and BMI 
at the start of the study were dichotomised at the median of each disease group 
separately. Baseline blood glucose was dichotomised at 8.0 mmol/1 for the fasting 
patient status or at 10.0 mmol/1 for the non-fasting status. Initial diastolic blood 
pressure (measured in diagnosing hypertension) was dichotomised at 105 mmHg. As 
noted previously [7], there were patients with comorbidity. Comorbidity reflects the 
existence at the start of the study of at least one of the other four chronic diseases. 
Patient compliance was defined as the attendance at the minimum number of control 
visits according to the guidelines and dichotomised on the basis of the frequency 
distribution: 100% compliance vs less than 100%. A variable indicating received follow-
up care was computed only for the cases of hypertension and diabetes mellitus, the 
number of cases in the other disease groups being too small. This variable reflects the 
agreement between the actual GP performance and the guidelines (observed vs 
expected) in each case, viz measurement of blood pressure in hypertensive patients and 
measurement of blood glucose in diabetic patients [3]. This care variable was also 
dichotomised on the basis of the frequency distribution: 100% agreement vs less than 
100%. 
Analysis 
Analysis of the data was performed per disease. The entire study period was divided 
in periods. For diabetes five 4-months periods and for the other diseases three 6-
months periods were considered according to the guidelines on the frequency of follow-
up visits [3]. The disease status indicators are presented as 3 or more follow-up 
measurements. Subgroups defined by the independent variables were used for subgroup 
analysis. Analyses were carried out with SPSS-X and SPSS-PC. Confidence intervals 
(CI) were computed at the 95% level. 
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73. Results 
Hypertension 
The proportion of hypertensive patients with a diastolic blood pressure below 95 
mmHg did not change during the study period (Table 7.3). Sex, age, initial blood pres-
sure, and baseline blood pressure showed no clear influence (data not shown). In 82% 
of the hypertensive patients the GP measured blood pressure at each control visit, in 
18% of die patients it was measured in 0-95% of the control visits. The measurement of 
the blood pressure by the GP at each control visit had no clear influence on the change 
in number of normotensive patients (Table 7.3). There was a decreasing trend in the 
number of normotensive patients in the noncompliant patient group. The number of 
hypertensive patients with a BMI below 27 kg/m2 showed an increasing trend in the 
compliant patient group only (data not shown). In the first and last observation period 
there were fewer normotensive patients in the comorbidity subgroup than in the non-
com orbidity subgroup (Table 7.4). 
Table 73. Proportion of hypertensive patients with diastolic blood pressure < 95 mmHg during three 6-
months periods controlled for GP care and patient compliance 
Received care: agreement with 
guidelines Patient compliance 
Total < 100% 100% < 100% 100% 
(N=613) (N=78) (N=500) (N=183) (N=414) 
Period %(95%CI) % (95% CI) % (95% CI) % (95% O) % (95% CI) 
1 74 (70.0-78.0) 76 (63.4-86.4) 74 (69.2-77.8) 79 (69.6-87.1) 73 (68.2-77.2) 
2 71 (66.4-74.6) 67 (54.0-78.7) 71 (66.5-75.2) 63 (52.2-733) 72 (67.7-76.5) 
3 74 (70.2-78.2) 77 (615-87.2) 74 (69.5-78.1) 65 (54.1-74.6) 77 (72.2-80.9) 
Table 7.4. Proportion of hypertensive patients with diastolic blood pressure < 95 mmHg during three 6-
months periods controlled for comorbidity 
Comorbidity 
Yes No 
(N=107) (N=506) 
Period % (95% CI) % (95% CI) 
1 69 (57.6-79.5) 75 (70.6-79.2) 
2 71 (58.9-81.0) 70 (66.0-74.8) 
3 72 (60.5-81.1) 75 (70.4-792) 
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Diabetes mellitus 
The Proportion of diabetic patients with a normoglycaemic status fluctuated during 
the five 4-months periods with a marked dip in the fourth period (Table 7.5). This 
proportion tended to increase in females, older diabetics, and patients who were 
hyperglycaemic at baseline (data not shown). In 46% of the diabetic patients the GP 
measured blood glucose at each control visit In 54% of the patients blood glucose was 
measured between 0 and 91% of the control visits. The measurement of blood glucose 
at each control visit had a positive influence on the number of diabetics with a 
normoglycaemic status from the second period until the end of the study (Table 7.5). 
Table 7.5. Proportion of diabetics with nonnoglycaemia during five 4-months periods controlled for GP 
care and patient compliance 
Period 
1 
2 
3 
4 
5 
Total 
(N=95) 
% (95% CI) 
47 (34.3-59.8) 
44 (30.9-58.6) 
49 (35.6-62.7) 
32 (20.3-45.0) 
47 (33.6-61.2) 
Received care: 
agreement with 
< 100% 
(N=50) 
% (95% CI) 
61 (43.4-76.0) 
39 (21.5-59.4) 
47 (28.3-65.7) 
22 (8.6-42.3) 
39 (20.2-59.4) 
guidelines 
100% 
(N=44) 
% (95% CI) 
27 (11.6-47.8) 
50 (29.9-70.1) 
52 (32.0-713) 
39 (22.9-57.9) 
55 (35.7-73.6) 
Patient compitane« 
< 100% 
(N=39) 
% (95% CI) 
40 (16.3-67.7) 
39 (13.9-68.4) 
53 (26.6-78.7) 
29 (10.3-56.0) 
53 (26.6-78.7) 
100% 
(N=55) 
% (95% CI) 
49 (34.4-63.7) 
46 (30.7-62.6) 
48 (32.0-63.6) 
33 (19.1^8.5) 
45 (293-61.5) 
Patient compliance in follow-up visits did not seem to influence the proportion of dia-
betics with nonnoglycaemia over time. Nonnoglycaemia tended to be more common in 
diabetics with comorbidity than in those without comorbidity, although the fluctuations 
over time in both subgroups were considerable (Table 7.6). The number of diabetics 
with a BMI < 27 kg/m2 fluctuated around 50%. These figures were not clearly influ-
enced by sex, age, BMI at baseline or patient compliance (data not shown). 
77 
ТвЫе 7.6. Proportioii of diabetics with nonnoglycaemia during five 4-months periods controlled for 
comorbidity 
Comorbidity 
Period 
Yes 
(N=48) 
%(95%CT) 
No 
(N=47) 
% (95% CI) 
56 (37.9-72.8) 
40 (21.1-613) 
52 (32J-70.6) 
36 (19.2-54.6) 
50 (29.9-70.1) 
37 (19.9-56.1) 
48 (29.4-67.5) 
46 (27.5-66.1) 
28 (12.7472) 
45 (26.4-643) 
Chronic ischemic heart disease 
The majority of CIHD patients in this study had already a diastolic blood pressure 
below 95 mmHg at baseline. Their number increased during the study period (Table 
7.7). Subgroup analysis revealed an increasing trend in women and older patients, and 
in the subgroup with a higher diastolic blood pressure at baseline, but comorbidity had 
no influence on these results (data not shown). The results in the small number of 
compliant patients do not allow any conclusion. 
Table 7.7. Proportion of CIHD patients with diastolic blood pressure < 95 mmHg during three 6-months 
periods controlled for patient compliance 
Total 
(N=66) 
Period % (95%(Д) 
Patient compliance 
< 100% 
(N=57) 
% (95% CI) 
100% 
(N=6) 
%(95%CT) 
87 (71.2-953) 
91 (77.9-97.4) 
91 (77.9-97.4) 
84 (663-94.5) 
89 (74.6-97.0) 
89 (74.6-97.0) 
100 (54.1-100.0) 
100 (54.1-100.0) 
100 (54.1-100.0) 
Chronic respiratory disease 
The overall incidence of exacerbations in patients with CRD did not change during 
the study period (Table 7.8). Analyses of subgroups showed an increased incidence in 
the older patients. Comorbidity did not seem to influence the incidence of exacerba­
tions over time. 
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Table ΊΑ. Incidence of exacerbations in CRD patients during three 6-months periods controlled for 
comorbidity in percentages 
Comorbidity 
Total Yes No 
(tf=115) (//=18) (N=97) 
Period % (95% CI) % (95% CI) % (95% CI) 
1 19(11.9-263) 22 (6.4-47.6) 19(11.4-27.7) 
2 22 (14.2-293) 33 (13.3-59.0) 20 (12.2-28.9) 
3 17 (9.7-233) 17 (3.6-41.4) 17 (9.7-25.4) 
Osteoarthritis 
The 17 patients with osteoarthritis presented three new episodes of joint complaints 
to their GPs, one in the second semester and two in the last six months. These 
incidence rates did not allow any further analysis of subgroups. 
7.4. Discussion 
The development and implementation of guidelines were aimed at improving the 
quality of care. Improvement of doctor's compliance with guidelines and of patient 
compliance with follow-up visits is generally expected to improve the outcome in 
patients [8], but there is little empirical evidence to support this. Therefore, this study 
was exploring the relation between performance and outcome. Ideally, such an 
intervention study should include a control group and/or baseline data collected in the 
period before intervention. For reasons previously explained [3], no such controlled 
design was adopted. 
In this study the disease status indicators of patients with five common chronic 
diseases fluctuated during the study period without a clear change. The results indicate 
improvement in some patient groups: 
non-compliant hypertensive patients decrease with regards to their normotensive 
status; 
in diabetic patients care according to guidelines increases the nonnogh/caemic status 
over time. 
More detailed analysis of patients whose disease status indicators improved and whose 
did not could reveal patient or care characteristics that facilitated the effects. The find­
ings here are only trends, as the confidence intervals show much overlap. Patient 
compliance and received care could only be adequately studied for patients with hyper­
tension and with diabetes mellitus for whom a simple quantitative measure could be 
computed. Similar trends might be visible in other patient groups if such measures 
would be available. Our results for diabetic patients are in accordance with a recent 
report on the influence of patient, doctor, practice and care characteristics on control in 
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diabetes mellitus, where only 15% of the variation of glycolysated haemoglobin between 
patients could be explained [9]. In another study participation by GPs in standard 
setting for common childhood conditions showed improved respiratory function in their 
patients [10]. We know of no other published studies in which outcome of care was 
related to patient compliance and GP performance. 
The disease status indicators used in this paper are those upon which GPs usually 
base their management in daily practice. They reflect 'short-term' results as in the case 
of diastolic blood pressure and blood glucose. For CIHD patients, however, diastolic 
blood pressure does not really reflect their disease status, but there is no obvious alt-
ernative short-term indicator. The disease status of patients with CRD could be 
reflected by peak flow or spirometrie measures. A proposal to include routine measure-
ment of peak flow could not reach consensus approval of the participating GPs. In the 
'standard' of the Dutch College of General Practitioners, that was published afterwards, 
routine peak flow measurement is included [11]. For patients with osteoarthritis no 
adequate numerical disease status indicator is available. Taking episodes of joint related 
problems as an indicator, just as exacerbations in CRD patients, was therefore a poor 
man's choice. For chronic diseases only long-term outcome measures as cardiovascular 
morbidity or mortality, diabetic retinopathy, respiratory function are really meaningful. 
Including, however, these measures in an intervention study requires a far longer study 
period. 
There could be an interaction between patient compliance and delivered care since 
delivery of optimal care is only possible in fully compliant patients. This interaction was 
not taken into account in our study. As none of the univariate analyses showed 
significant differences it did not seem meaningful to carry out multivariate analysis. 
Taking into account five chronic diseases simultaneously implies a broad approach 
rather than a study in detail. One could assume that GP performance is not related to a 
single disease but a general GP characteristic. We did not find any indication for this 
assumption in the data on GP performance [3], or in the data shown here: there was no 
relation between overall GP performance and outcome expressed in the proportion of 
patients who kept stable or improved on the disease status indicators. 
Apparently, the relation between delivered and received care and outcome is more 
complex than is generally expected. Further study should focus on measures represent-
ing elements of care that are considered essential. In addition, more attention is needed 
to indicators that reflect the course of a chronic disease, to be used in research as well 
as in daily care. 
7.5. Conclusions 
The development and implementation of guidelines for the follow-up care of 
patients with chronic diseases may have a positive effect on the short-term disease 
status indicators. In this study only some positive trends were found and some influence 
of received care and patient compliance. Measuring the outcome of GP care for 
patients with chronic diseases requires the availability of meaningful quantitative disease 
status indicators. To elucidate the influence of GP compliance with guidelines for 
optimal care, of patient compliance, and of their interaction will require further study. 
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8. Discussion 
The study reported in this thesis is a part of the Dutch National Survey of General 
Practice, which is aimed at gaining insight into the patterns of diseases presented in 
general practice and the care provided by general practitioners (GPs). This part of the 
survey focused on chronic diseases with special attention to comorbidity and quality of 
care. In this last chapter conclusions are formulated, and methodological issues and the 
relevance of this study for investigators and general practitioners are discussed. 
8.1. Conclusions 
The following conclusions are formulated for the research questions mentioned in 
chapter 1. 
a. How can comorbidity be defined? 
From a systematic search of the relevant literature we concluded that there is no 
uniformity in defining comorbidity or in the diseases that are considered in studying 
comorbidity. We proposed a definition and classification based on the presumed 
relationship between "diseases. 
b. What is the validity of diagnoses of chronic diseases in general practice? 
Diagnoses registered on patient records in general practice can be considered largely 
valid, since in our study of the records of 15 GPs we found only small proportions of 
false positive diagnoses (less than 4%). · 
с What is the prevalence of comorbidity of chronic diseases? 
The point-prevalent concurrence of the five most common chronic diseases in general 
practice (hypertension, diabetes mellitus, chrome ischaemic heart disease, chronic 
respiratory disease, and osteoarthritis of knee and/or hip) had a high prevalence in 
patients with at least one of these diseases, especially in patients of 65 years and older. 
The highest rates öf comorbidity were found in patients of 65 and over with diabetes 
mellitus, and with osteoarthritis. 
d What is the influence of comorbidity of chronic diseases on GP consultation rates and 
on the incidences of intercurrent diseases? 
Consultation rates in general practice tended to be higher for patients with comorbidity 
than foT patients with only one of the five chronic diseases, and compared with patients 
without any chronic disease. Patients with comorbidity of chronic diseases tended to 
have higher incidence rates of intercurrent morbidity than patients without comorbidity. 
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e. Does the actual care of GPs during the follow-up of patients with chronic diseases 
become more in agreement with the consensus guidelines for optimal care in course of 
time? 
The actually delivered care by general practitioners did not come to full agreement with 
the guidelines in the course of time. However, agreement tended to increase with time, 
particularly in the care for patients with hypertension and diabetes mellitus concerning 
actions that had to be carried out at each visit 
f. What is the effect of the implementation of guidelines for follow-up care on the disease 
status of patients with chronic diseases in general practice? 
The disease status of the five chronic diseases studied fluctuated during the study 
period without showing a substantial change. Trends were found for a relation between 
patient compliance and increase of normotensive status in hypertensive patients, and 
between performance of general practitioners and increase of normogrycaemic status of 
diabetic patients. 
8.2. Methodological aspects 
In performing research in general practice one meets many and complex problems 
which need to be dealt with. Four of these are discussed here: diagnostic validity, the 
prevalence of comorbidity, the analysis of the influence of comorbidity on consultation 
rates and morbidity, and the use of a control group and/or a control period. 
The validity of diagnoses of chronic diseases was established by measuring the true 
positive and false positive diagnoses. The picture of validity is, however, not complete 
without measuring true negative and false negative diagnoses. This would require a 
screening procedure in (a sample of) the practice population for five chronic diseases 
which was not feasible within this study. 
The prevalence of comorbidity of chronic diseases depends greatly on the number 
of diseases that is considered. Although the chronic diseases included in this study are 
responsible for the majority of chronic morbidity in general practice, the presented 
figures of comorbidity are strictly valid only within the scope of these five chronic 
diseases. 
The influence of comorbidity on consultation rates and intercurrent morbidity was 
difficult to measure. Results are at risk of being biased by patient age, and possibly by 
other diseases present on which no information is available. Many diseases are age-
dependent or aging-related. In studying a specific disease the influence of age can be 
controlled for methodologically. In the case of a chronic disease it is difficult to 
disentangle the influence of age and of the disease itself. In the case of comorbidity this 
is even more complex. Another problem is the overlap between the different co-
morbidity subgroups: patients with diabetes mellitus and hypertension appear in both 
the comorbidity subgroup of hypertensive patients and diabetic patients. 
The effect of guidelines on actual care and patient outcome is also difficult to 
establish. The use of a control group or of measurements prior to the intervention are 
methodologically recommended, or sometimes even considered obligatory. However, it 
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appears virtually to have a true control group or baseline period. GPs in a control 
group cannot be asked to continue their usual care without taking notice of medical 
literature or educational programs during the study period. In the case of a baseline 
measurement the registration of activities on the same form that is used during the 
intervention period will undoubtedly influence the GPs in their performance in the 
direction of the intervention. These considerations concern the general question 
whether it is advisable to strive for the creation of a laboratory-like situation in general 
practice studies especially in view of the generalizability of the results. In our study we 
have, after careful consideration, decided not to do this, although we realize that this 
limits the internal validity of our study. 
83. Relevance for investigators 
The revival of attention for the phenomenon of comorbidity of chronic diseases is a 
good opportunity to combine efforts of investigators in order to reach more uniformity 
in definition, operationahzation and use of comorbidity in epidemiological and clinical 
studies. A first step should include the explicit mentioning of definitions and of diseases 
considered. A further step should be the development of a classification of comorbidity, 
of a measure of comorbidity, and uniform handling of comorbidity in epidemiological 
and clinical studies. We suggested a classification based on the type of relationship 
between diseases: concurrent, cluster, causal, and complicating comorbidity. This 
classification needs further validation. Finally, the relevance of comorbidity should be 
brought to the attention of investigators, especially of those who study chronic diseases. 
The relevance for dairy practice of such studies is enhanced when comorbidity is taken 
into account Therefore, further descriptive studies should be undertaken in order to 
gain more insight into comorbidity and its relation to age, sex, and other patient charac-
teristics. Comorbidity presents a real challenge for epidemiological and clinical research. 
General practice in The Netherlands harbours a resource of morbidity and mortality 
data which is largely underestimated. Internationally, Dutch general practice is almost 
unique in its fixed practice list. This offers the possibility of computing epidemiological 
denominators and the completeness and validity of morbidity data, depending of course 
on the GP's accuracy. This unique position will be further enhanced by the increasing 
use of computerized information systems in the near future. This should lead to a wider 
use of general practices for descriptive studies and also as a sampling frame for case 
control and intervention studies. 
Until now, the structure, process, and outcome of care have mostly been studied 
independently from each other. Measures of delivered care were not related to data on 
outcome in patients who received that care. The implementation of guidelines has so 
far mostly been evaluated at the level of institutions or even at a national level. In our 
view, the implementation of guidelines should be accompanied by feedback at the level 
of individual GPs and sometimes even at the level of individual patients. The require-
ment for GPs to register their performance provides a secondary, but nevertheless 
important benefit in that it makes them more aware of their performance. The 
formulation and implementation of guidelines, and registration of performance permit 
studies of the quality of GP care: information on GP performance is easily available at 
the level of the individual patient When this information is linked with outcome 
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measures, obtained either by the GP or by extra data collection from patients, quality of 
care studies become possible. The performance measures should be disease-specific, 
underwritten by GPs as considered useful, and should be related to meaningful 
outcome measures. The disease-specific outcome measures should provide either insight 
into the short term course of the disease or information on prognostic factors that are 
generally considered relevant for the specific disease. Studies on quality of care should 
not only focus on disease-specific outcome parameters but also on the functional health 
status in its broadest sense. The relation between performance and outcome is not that 
simple as could be expected, especially in the comprehensive care of patients with 
chronic diseases. It is difficult to define performance measures that reflect important 
elements of the care process. Measuring real outcome in patients with chronic diseases 
requires longitudinal studies in which many other interventions than the doctor's 
performance may occur. 
8.4. Relevance for general practitioners 
The objective of this study was to contribute to the knowledge about chronic 
diseases in general practice. The results present a kaleidoscopic view of this field. This 
study illustrates and emphasizes the very important position of GPs in the care of 
patients with chronic diseases. Chronic diseases are diagnosed mostly by GPs and the 
validity of their diagnoses is confirmed in this study. Comorbidity of chronic diseases is 
a quantitatively important phenomenon in patients over 65 years old and it will increase 
in the near future. These patients consult their GP frequently, mainly for acute 
intercurrent diseases. Consequently, GPs are confronted with multiple health problems 
which may pose difficult problems. The GP has the most complete overview of all these 
problems and is in the best position to manage these complex situations. Patients with 
comorbidity appeal strongly to the generalistic nature of a GP's work. This important 
position of GPs in The Netherlands should be elaborated and GPs should profit from it 
in maintaining and reinforcing their position in the health care system for patients with 
chronic diseases. The recognition of comorbidity as an important feature of general 
practice should have consequences for the single-disease standards of the Dutch College 
of General Practitioners. 
The formulation and implementation of guidelines in general practice, aimed at 
improving the quality of care of patients with chronic diseases is an intensive job. The 
agreement between the guidelines and actual performance in this study was already 
high at the beginning with regard to some measures and did therefore not change 
appreciably during the implementation. In other measures trends in the positive 
direction were found. There is a need for further discussion on the relevance of 
detailed performance measures, on whether full agreement between guidelines and 
performance in all patients should be pursued, and on whether less than 100% \ 
agreement between guidelines and performance reflects qualitatively inferior care. One 
of the main objectives of the Dutch standards is improving the outcome in patients by 
optimal GP performance. Eventually, standards should list only those performance 
items which have proven to be effective on outcome parameters. 
In this study a simple model of peer review was used. More intensive feedback on 
actually delivered care in combination with educational programs focusing on deter-
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mined needs might have more success. Such a diversity of methods should be built into 
quality improvement programs for general practitioners. There were no significant 
effects of GP performance on the disease status of patients with chronic diseases in this 
study, so no conclusions can be drawn from this part The last two chapters of this 
thesis present a model for the evaluation of care which can be used in peer review 
groups, and in vocational training. In this way GPs can evaluate systematically their 
performance in delivering care and its effects on patients. 

9. Summary 
The study reported in this thesis is a part of the Dutch National Survey of General 
Practice, which is aimed at gaining insight in the patterns of diseases presented in 
general practice and in the care provided by general practitioners (GPs). This part of 
the survey focuses on chronic diseases with special attention to comorbidity and quality 
of care. 
Chapter 1 gives background information on the main themes of this study, and lists 
the questions which this study aims to answer. It also provides some information on the 
setting of general practice in The Netherlands. The prevalence of chronic diseases is 
expected to increase in the near future due to the 'greying' of the population over the 
next decades. Care for patients with chronic diseases is mainly aimed at the compres-
sion of disabling lifetime. Comorbidity of chronic diseases, the existence of more than 
one chronic disease in one patient, has until recently not received much attention. Yet 
it is a reality of the daily practice of GPs who have to deal with all diseases of a patient. 
The following five chronic diseases were chosen for this study: hypertension, chronic 
ischaemic heart disease, diabetes mellitus, chronic respiratory disease, and osteoarthritis 
of knee and/or hip. 
Chapter 2 reports the results of a search of the literature aimed at clarifying 
differences in defining and handling the phenomenon of comorbidity in order to 
contribute to greater uniformity. A systematic Medline search using the key word 
'comorbidity' yielded 70 publications between 1985 and 1991. A review of these 
publications revealed that comorbidity was defined explicitly in 33 publications. These 
definitions rested upon the type of relationship between diseases: co-existence of 
diseases, presence of diseases additional to an index disease, and association or 
correlation between diseases. Diseases that were considered in studying comorbidity 
were mostly of a chronic nature (diabetes mellitus, cancer, heart disease). In the 
reviewed publications comorbidity was most frequently used as an independent variable. 
Comorbidity was handled differently, varying from a simple measure reflecting the 
presence or absence of any comorbid disease to complex comorbidity measures 
weighted for disease severity. Mortality or survival was the most frequently studied 
outcome variable. It was concluded that for a better understanding of the role of 
comorbidity there is a need for an agreed definition, for explicit mentioning of the 
diseases considered, and for standardization of measures of comorbidity. 
In chapter 3 a study of the validity of diagnoses of chronic diseases is reported. The 
certainty of a diagnosis of a chronic disease is most important for the patient but also 
for morbidity studies. The certainty of a diagnosis was operationalized by measuring the 
agreement with diagnostic criteria according to the International Classification of 
Health Problems in Primary Care. Data on the performance and results of diagnostic 
procedures were collected retrospectively by 15 GPs in seven general practices. The 
agreement with the diagnostic criteria for the diseases diagnosed in general practice was 
high, ranging from 96% true positive cases in diabetes mellitus to 58% in chronic 
respiratory disease. The highest rate of false positive cases was 4%. The variation 
between the 15 GPs in the agreement of the diagnoses of their patients with the 
diagnostic criteria was substantia]. It was concluded that the diagnoses of the five 
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diseases registered in general practice are generally valid with low numbers of false 
positive cases. 
The extent of comorbidity of five chronic diseases which were in agreement with 
diagnostic criteria is described in chapter 4. In the population under 65 years of age 
comorbidity occurred in only 0.3%. In persons of 65 years and older 23% suffered from 
one or more of the diseases studied. Within this patient group 15% suffered from more 
than one of the diseases. Patients with osteoarthritis, and with diabetes mellitus had the 
highest rates of comorbidity. Comorbidity is thus a clinical reality of general practice. 
The influence of comorbidity of chronic diseases on the frequency of consultations 
of GPs and on intercurrent morbidity is described in chapter 5. For this purpose the 
number of consultations and the incidence rates of intercurrent morbidity were studied 
during 21 months in five cohorts of patients grouped according to their chronic disease. 
Within each cohort a distinction was made between patients with one and patients with 
two or more of the five studied diseases. In each cohort patients with comorbidity had 
higher consultation rates than single-disease patients. Intercurrent diseases were 
presented more frequently to the GP by patients with comorbidity than single-disease 
patients. Most intercurrent morbidity consisted of acute common diseases as myalgia, 
upper respiratory tract infection and urinary tract infection. Compared to reference 
groups without any chronic disease, single-disease patients had higher consultation rates 
but no higher incidence rates of intercurrent morbidity. 
Chapter б describes a study on the effect of formulating and implementing 
guidelines for optimal follow-up care of patients with chronic diseases on actually 
delivered care. In monthly meetings with the 15 participating GPs consensus was 
reached on guidelines, followed by their implementation in daily practice. The imple­
mentation was supported by feeding back information on actual performance integrated 
in peer review meetings. At the same time the GPs registered data on the care 
delivered to their patients during 21 months. The agreement between guidelines and 
actually delivered care to five groups of patients was expressed in performance 
measures per disease. An overall performance measure was computed. Additionally, an 
inventory was made of problems occurring during the implementation of these 
guidelines. The performance did not reach full agreement with the guidelines, but 
agreement tended to increase in the course of time. This was particularly noticeable in 
the performance towards patients with hypertension, and with diabetes mellitus with 
regard to actions that had to be carried out at each visit There was no indication that 
agreement between guidelines and actual performance is an overall GP characteristic, 
rather than specific for a single disease. Problems mentioned by the GPs as underlying 
cause for discrepancies between guidelines and performance frequently concerned 
organizational matters. Peer discussions led to practicable suggestions. It was argued 
that the formulation and implementation of guidelines will improve more easily 
performance with an immediate impact on the course and management of a disease 
than performance with only an indirect influence on the course of a disease. 
Chapter 7 describes a study on the effect of guidelines for optimal follow up care on 
patient outcome measures. During the implementation of these guidelines the GPs not 
only registered data on the actually delivered care, as analyzed in chapter 6, but also 
the results of measurements and presented morbidity. For all five chronic, diseases 
outcome measures reflecting the disease status were defined. Patient compliance to 
follow-up visits, and GP performance according to the guidelines were used as indepen-
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dent variables. The disease status indicators of the five patient groups fluctuated during 
the study period of 21 months without showing a substantial change. Trends were found 
for a relation between patient compliance and increase of normotensive status in 
hypertensive patients, and between performance of GPs and increase of nonno-
glycaemic status of diabetics. No indications were found for an overall, non-disease-
related relationship between the compliance of GPs towards care according to the 
guidelines and change of disease indicators of their patients. It was concluded that the 
outcome measures for patients with chronic ischaemic heart disease (normal blood 
pressure), chronic respiratory disease (number of exacerbations), and osteoarthritis 
(number of episodes of joint related problems) do not well reflect their disease status. 
Evaluation of the implementation of guidelines requires the availability of meaningful 
performance and outcome measures. 
In chapter 8 conclusions are formulated, and methodological issues and the 
relevance of this study for investigators and general practitioners are discussed. Studies 
on the effects of comorbidity are at risk of being biased by, for example, age. This can 
be controlled for methodologically, but the relevance of studying a net effect of 
- comorbidity for daily medical practice can be doubted. It is suggested that the applica-
tion of methodologically ideal models reduces the external validity of the results of 
studies of the delivery of care and its effects on patients. For epidemiological and 
clinical investigators the issue of comorbidity presents a real challenge. It is recom-
mended to pursue more uniformity in defining and handling comorbidity in research, 
and studies on the relation with age, sex, and other patient characteristics. The almost 
unique source of morbidity and mortality data in the Dutch general practices deserves 
further use. Further development of research on quality of care, with simultaneous 
measurement of performance and outcome, is indicated. The functional health status of 
patients should be incorporated in measuring outcome. For general practitioners this 
study confirms their important position in the care for patients with chronic diseases. 
Patients with comorbidity of chronic diseases appeal strongly to the generalistic nature 
of a GP's work. Therefore comorbidity should be systematically included in the Dutch 
standards for optimal GP care. Programs aimed at improving quality of care should 
include diverse strategies. The relevance of pursuing full agreement between guidelines 
and actually delivered care should be discussed. The model presented in this study can 
well be used in educational programs focusing on the implementation of a systematic 
evaluation of the effects of delivered care in general practice. 
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Samenvatting 
In deze dissertatie wordt een deelonderzoek beschreven van de Nationale Studie naar 
Ziekten en Verrichtingen in de Huisartspraktijk. De Nationale Studie had tot doel in-
zicht te verkrijgen in de presentatie van ziekten, klachten en problemen in de huisarts-
praktijk en in de door huisartsen naar aanleiding hiervan ondernomen acties. Chroni-
sche ziekten en in het bijzonder comorbiditeit en kwaliteit van zorg zijn onderwerp van 
dit deelonderzoek van de Nationale Studie. 
In hoofdstuk 1 vindt men achtergrondinformatie over de thema's van het onderzoek 
en de onderzoeksvragen. De positie van de huisarts in het Nederlandse gezondheids-
zorgsysteem wordt kort toegelicht De prevalentie van chronische ziekten zal naar ver-
wachting in de naaste toekomst toenemen door de 'vergrijzing' van de bevolking. De 
zorg voor patiënten met chronische ziekten is vooral gericht op de vermindering van het 
aantal jaren met beperkingen. Aan comorbiditeit, het vóórkomen van meer dan een 
ziekte bij dezelfde patiënt, is nog weinig aandacht besteed. Comorbiditeit behoort tot de 
realiteit van de dagelijkse praktijk van de huisarts die met alle ziekten van een patiënt 
rekening moet houden. Voor dit onderzoek zijn vijf chronische ziekten gekozen: hyper-
tensie, chronische ischemische hartziekten, diabetes mellitus, chronische aspecifieke 
respiratoire aandoeningen en gonartrose en/of coxartrose. 
In hoofdstuk 2 wordt een literatuuronderzoek beschreven naar de verschillen in defi-
nities van comorbiditeit en de plaats van comorbiditeit in onderzoeken. Het doel van 
dit literatuuronderzoek was een bijdrage te leveren aan een grotere uniformiteit 
Systematisch zoeken met behulp van MedLine leverde 70 publicaties op uit de jaren 
1985-1991. In 33 publicaties werd comorbiditeit expliciet gedefinieerd. Deze definities 
bleken gebaseerd op de aard van de relatie tussen ziekten: het tegelijkertijd vóórkomen 
van ziekten, de aanwezigheid van een andere ziekte dan de bestudeerde of 'index-ziek-
te' en associatie of correlatie tussen ziekten. De ziekten die in beschouwing werden 
genomen bij het bestuderen van comorbiditeit waren meestal van chronische aard (dia-
betes mellitus, kanker, hartziekte). In de bestudeerde publicaties fungeerde comorbi-
diteit meestal als onafhankelijke variabele. De wijze waarop comorbiditeit in de analyse 
van de gegevens werd gebruikt varieerde van eenvoudigweg de aan- of afwezigheid van 
enige andere ziekte tot gecompliceerde maten voor comorbiditeit met weging voor de 
ernst van ziekten. De meest gebruikte uitkomstvariabele was sterne of overleving. De 
conclusies van dit literatuuronderzoek zijn dat er behoefte is aan een algemeen 
onderschreven definitie, aan het expliciet vermelden van de ziekten die in beschouwing 
worden genomen en aan standaardisatie van maten voor comorbiditeit 
In hoofdstuk 3 wordt verslag gedaan van een onderzoek naar de validiteit van de 
gestelde diagnoses van chronische ziekten. Zekerheid over de diagnose is belangrijk 
voor patiënten, maar ook voor studies naar frequenties van ziekten. De zekerheid over 
de diagnose werd afgemeten aan de mate waarin werd voldaan aan de diagnostische cri-
teria volgens de 'International Classification of Health Problems in Primary Care'. 
Retrospectief verzamelden 15 huisartsen in zeven huisartspraktijken gegevens over diag-
nostische handelingen en resultaten van diagnostisch onderzoek. De overeenkomst met 
de diagnostische criteria varieerde van 96% terecht positieve diagnoses diabetes 
mellitus tot 58% van de patiënten met chronische aspecifieke respiratoire aandoenin-
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gen. Het hoogste percentage fout-positieve diagnoses was 4. De 15 huisartsen verschil-
den onderling sterk wat betreft het voldoen van de door hen gestelde diagnoses aan de 
diagnostische criteria. De conclusie van dit onderzoek luidt dat de diagnoses van de vijf 
chronische ziekten, geregistreerd in de huisartspraktijk, in het algemeen valide zijn met 
lage aantallen fout-positieve diaposes. 
De omvang van comorbiditeit bij vijf chronische ziekten voor zover deze voldeden 
aan de diagnostische criteria wordt beschreven in hoofdstuk 4. In de bevolking jonger 
dan 65 jaar kwam comorbiditeit maar bij 0,3% van de mensen voor. Bij personen boven 
65 jaar was 23% bekend met tenminste een van de vijf chronische ziekten. Van deze 
laatsten heeft 15% meer dan één chronische ziekte. Comorbiditeit kwam het meest fre-
quent voor bij patiënten met artrose en met diabetes mellitus. Comorbiditeit is dus 
realiteit in de huisartspraktijk. 
De invloed van comorbiditeit van chronische ziekten op de frequentie van contacten 
met de huisarts en op het optreden van andere ziekten wordt beschreven in hoofdstuk 5. 
Gedurende 21 maanden werd het aantal contacten en het aantal nieuw optredende 
ziekten bepaald uitgaande van elke van de vijf chronische ziekten. Binnen iedere groep 
werd onderscheid gemaakt tussen patiënten met één of meer van de vijf ziekten. Deze 
laatsten zijn de patiënten met comorbiditeit Binnen alle groepen hadden de patiënten 
met comorbiditeit een hogere contactfrequentie dan de patiënten met één chronische 
ziekte. Ook presenteerden de patiënten met comorbiditeit meer nieuwe ziekten aan de 
huisarts dan de patiënten'met één chronische ziekte. Myalgie, bovenste-luchtweginfectie 
en urineweginfectie waren de meest frequente nieuwe ziekten. In vergelijking met 
referentiegroepen zonder chronische ziekte hadden patiënten met uitsluitend hyperten-
sie en patiënten met uitsluitend diabetes mellitus een hogere contactfrequentie, maar 
presenteerden zij niet meer nieuwe ziekten. 
In hoofdstuk 6 wordt verslag gedaan van een onderzoek naar effecten van het op-
stellen en invoeren van richtlijnen voor optimale lange-termijnzorg op de daadwerkelijk 
verleende zorg aan patiënten met chronische ziekten. Tijdens maandelijkse bijeenkom-
sten stelden de 15 deelnemende huisartsen, op basis van consensus, richtlijnen op en 
voerden deze in in de dagelijkse praktijk. De invoering van de richtlijnen werd onder-
steund door gegevens over het feitelijk handelen terug te koppelen aan de huisartsen en 
deze informatie te bespreken met behulp van de methode van onderlinge toetsing. De 
huisartsen registreerden gedurende 21 maanden gegevens over de door hen verleende 
zorg. Per ziekte werden maten geconstrueerd voor overeenstemming tussen de richtlij-
nen en het feitelijk handelen. Ook werd een totaalmaat geconstrueerd voor het han-
delen van de huisarts. Daarnaast werden de problemen die rezen tijdens de invoering 
van de richtlijnen geïnventariseerd. Er werd geen volledige overeenstemming tussen de 
richtlijnen en het feitelijk handelen bereikt Wel was er in de loop van de tijd een 
toenemende mate van overeenstemming. Dit was vooral duidelijk voor handelingen die, 
in geval van hypertensie en diabetes mellitus, tijdens elk contact uitgevoerd dienden te 
worden. De mate van overeenkomst tussen de richtlijnen en het feitelijk handelen bleek 
geen algemeen kenmerk van huisartsen in plaats van een ziekte-gebonden huisarts-
kenmerk. De problemen die door de huisartsen werden genoemd als verklaring voor 
het ontbreken van de overeenstemming tussen de richtlijnen en het handelen waren 
vaak van organisatorische aard. De discussies daarover tijdens de bijeenkomsten 
leverden praktisch toepasbare adviezen op. Er wordt betoogd dat het opstellen en 
invoeren van richtlijnen eerder een positieve invloed heeft op handelingen die direct 
93 
gerelateerd zijn aan het beloop van de ziekte dan op handelingen die indirect verband 
daarmee houden. 
In hoofdstuk 7 wordt een onderzoek beschreven over effecten van de invoering van 
richtlijnen voor optimale lange-termijnzorg op het ziektebeloop bij patiënten. Tijdens de 
invoering van deze richtlijnen registreerden de deelnemende huisartsen niet alleen 
gegevens over hun feitelijk handelen (zie hoofdstuk 6), maar ook de resultaten in maat 
en getal en gepresenteerde ziekten. Voor ieder van de vijf chronische ziekten werden 
klinische uitkomstmaten geconstrueerd als indicatoren voor het beloop van de ziekte. 
De bezoektrouw van patiënten en de mate waarin het feitelijk handelen van de huisarts 
overeenkomt met de richtlijnen waren de onafhankelijke variabelen. De indicatoren 
voor het beloop van de ziekte schommelden gedurende de onderzoeksperiode zonder 
duidelijk te veranderen. Er lijkt verband te bestaan tussen bezoektrouw van patiënten 
en een toename van het aantal goed ingestelde hypertensiepatiënten, en tussen het 
handelen van de huisarts en een toename van het aantal goed ingestelde diabetes-
patiënten. Er waren geen aanwijzingen voor een algemeen, niet-ziektegebonden, ver-
band tussen het handelen van huisartsen volgens de richtlijnen en veranderingen in de 
ziekte-indicatoren van hun patiënten. De conclusie is dat de gekozen uitkomstmaten 
voor patiënten met een chronische ischemische hartziekte (normotensie), chronische 
aspecifieke respiratoire aandoeningen (aantal exacerbaties) en artrose (aantal episoden 
gewrichtsproblemen) het ziektebeloop niet goed weergeven. Om de invoering van richt-
lijnen te kunnen evalueren moeten zinvolle uitkomstmaten beschikbaar zijn. 
In hoofdstuk 8 worden conclusies geformuleerd en methodologische aspecten bedis-
cussieerd. Ook wordt de betekenis van dit onderzoek voor onderzoekers en voor huis-
artsen besproken. Onderzoek naar effecten van comorbiditeit worden potentieel ver-
stoord door bijvoorbeeld leeftijd. Hoewel hiervoor methodologisch gecorrigeerd kan 
worden, kan men zich afvragen wat de relevantie is voor de dagelijkse praktijk van het 
bestuderen van het 'netto' effect van comorbiditeit Een methodologisch ideale onder-
zoeksopzet bij onderzoek ' naar verleende zorg en de effecten daarvan op patiënten 
vermindert de externe validiteit van de gevonden resultaten. Voor epidemiologisch en 
klinisch onderzoek vormt het verschijnsel comorbiditeit een echte uitdaging. Aanbevo-
len wordt om meer uniformiteit na te streven in de definitie en het gebruik van comor-
biditeit , en om de relatie tussen comorbiditeit en leeftijd, geslacht en andere patiënt-
kenmerken nader uit te diepen. Huisartspraktijken in Nederland vormen daartoe een 
vrijwel unieke lokatie gezien de beschikbaarheid van gegevens over ziekte en sterfte. 
Onderzoek naar kwaliteit van zorg, met het gelijktijdig meten van handelen en uitkom-
sten, dient verder te worden ontwikkeld. Als uitkomstmaat is de functionele gezondheid 
van patiënten hierbij goed bruikbaar. Dit onderzoek bevestigt de belangrijke positie van 
de huisarts in de zorg voor patiënten met chronische ziekten. De zorg voor patiënten 
met comorbiditeit appelleert sterk aan het generalistische karakter van het werk van de 
huisarts. Comorbiditeit zou een vaste plaats moeten krijgen in de standaarden van het 
Nederlands Huisartsen Genootschap. Programma's die gericht zijn op verbetering van 
de kwaliteit van zorg dienen verschillende methoden te omvatten. Besproken moet 
worden wat het belang is van volledige overeenstemming tussen richtlijnen en het 
feitelijk handelen van huisartsen. Het model dat in dit onderzoek gebruikt is, is geschikt 
voor scholingsprogramma's die zijn gericht op het systematisch evalueren van de 
effecten van de verleende huisartsgeneeskundige zorg. 
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Résumé 
L'étude rapportée dans cette thèse est une contribution à l'Enquête Nationale néerlan-
daise sur la Médecine Générale entreprise pour préciser la nature des affections 
rencontrées par les omnipraticiens ainsi que les sanctions thérapeutiques qu'ils leur 
opposent Cette partie de l'enquête porte sur les maladies chroniques et plus particu-
lièrement sur les polypathologies et la qualité des thérapeutiques mises en oeuvre. 
Le Chapitre 1 situe les principaux volets de cette étude et énumère les questions . 
auxquelles elle ambitionne de répondre. Π renseigne également sur l'organisation de la 
médecine générale aux Pays-Bas. On peut tabler sur une augmentation de la prévalence 
des maladies chroniques dans les prochaines décades. Le traitement des maladies 
chroniques vise essentiellement à repousser l'échéance de l'état d'impotence. Les états 
polypathologiques chroniques, c'est-à-dire de coexistence de plus d'une affection 
chronique chez le même malade, n'ont guère retenu l'attention jusqu'à présent. Ces 
situations sont pourtant le lot quotidien des généralistes qui ont à gérer l'ensemble des 
pathologies présentées par leurs patients. Pour cette étude ont été retenues les cinq 
affections chroniques suivantes: hypertension permanente, ischémie myocardique chro-
nique, diabète sucré, affections respiratoires chroniques, arthrose du genou et/ou de la 
hanche. 
Le Chapitre 2 rapporte les résultats des recherches bibliographiques entreprises 
pour faire le point sur les différentes acceptions et utilisations du concept de pofypa-
thologie et contribuer ainsi à une meilleure uniformisation de la terminologie. Une 
recherche MedLine systématique à partir du mot clé 'polypathologie' aboutit à la 
sélection de 70 publications parues entre 1985 et 1991. Leur examen révéla que la 
définition du terme 'polypathologie' était explicite dans 33 d'entre elles. Les définitions 
se fondaient sur la nature des relations entre différentes affections: coexistence de 
pathologies différentes, existence de pathologies surajoutées à une affection principale 
et associations ou corrélations entre plusieurs pathologies. Les maladies prises en 
considération pour l'étude de polypathologies étaient pour la majorité d'entre elles de 
nature chronique (diabète sucré, cancers, cardiopathies). Dans toutes ces publications, 
la polypathologie était le plus souvent considérée comme une variable indépendante. Le 
terme de polypathologie recouvrait des significations différentes, allant de la simple 
appréciation de l'existence ou non d'une maladie concomitante jusqu'à la notion 
complexe d'appréciation d'un degré de gravité. L'intérêt se portait le plus souvent sur le 
taux de mortalité ou les chances de survie. On peut conclure de ces recherches que, 
pour une meilleure compréhension des phénomènes liés aux états de polypathologies, il 
est nécessaire de trouver un consensus sur la définition de ce terme, de préciser la 
nature des maladies prises en considération et de standardiser les paramètres d'évalua-
tion de ces états. 
Le Chapitre 3 est consacré à l'étude de la validité des diagnostics posés en matière 
de maladies chroniques. Si la fiabilité d'un diagnostic est d'importance capitale pour le 
patient, elle l'est aussi pour celui qui étudie la morbidité. La validité des diagnostics a 
été appréciée en se référant aux critères retenus pour la Classification Internationale 
des Problèmes de Santé pour les Soins Primaires. Les données sur les démarches 
diagnostiques et leurs résultats furent recueillis de façon rétrospective auprès de quinze 
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omnipraticiens exerçant dans sept cabinets médicaux. La concordance avec les critères 
diagnostiques fut trouvée très bonne, allant de 96% de vrais positifs pour le diabète 
sucré à 58% pour les affections respiratoires chroniques. Le taux de faux positifs le plus 
élevé était de 4%. De nettes différences de concordance entre diagnostics posés et 
critères diagnostiques furent observées d'un praticien á l'autre. En définitive, on peut 
dire que, pour ce qui est des cinq maladies choisies pour cette étude, les diagnostics 
posés en médecine générale sont généralement corrects avec peu de faux positifs. 
Le Chapitre 4 traite de l'importance de la polypathologie afférente aux cinq 
affections chroniques étudiées, satisfaisant aux critères diagnostiques. Cette polypatho-
logie ne touche que 0,3% de la population de moins de 65 ans. Parmi les gens âgés de 
65 ans et plus, on compte 23% de personnes atteintes d'une ou plusieurs des maladies 
étudiées. Dans ce groupe de patients, 15% présentent plus d'une maladie. Les person-
nes souffrant d'arthrose et de diabète sucré sont les plus nombreuses à présenter une 
polypathologie qui se trouve donc être en effet une entité clinique rencontrée en 
médecine générale. 
L'influence des états de polypathologie d'affections chroniques sur le taux de 
fréquentation des cabinets des omnipraticiens et sur la fréquence des maladies intercur-
rentes est analysée dans le Chapitre 5. Pour ce faire, ces deux paramètres ont été 
colligés sur une période de 21 mois, pour cinq cohortes de malades répartis selon la 
nature de leurs affections chroniques. Pour chacune de ces cohortes, la distinction était 
faite entre patients à pathologie unique et patients porteurs de deux ou plus des cinq 
affections en cause. Dans tous les cas, on a constaté que les malades à polypathologie 
consultaient plus souvent que ceux qui ne souffrent que d'une seule affection. De 
même, la fréquence d'apparition de maladies intercurrentes était majorée pour les 
malades à polypathologie. Ces maladies intercurrentes étaient généralement des 
épisodes aigus d'affections banales, telles que myalgie, infections des voies respiratoires 
supérieures et de la sphère urinaire. D'autre part, par rapport aux groupes témoins, 
sans pathologie chronique, on relevait bien une majoration du nombre de consultations, 
mais sans modification de l'incidence de maladies intercurrentes. 
Le Chapitre 6 est consacré à l'étude de l'impact sur la pratique journalière des 
directives thérapeutiques formulées et mises en oeuvre pour optimiser le suivi médical 
de malades chroniques. Des réunions mensuelles avec les quinze généralistes engagés 
dans l'étude ont abouti à un consensus sur des directives et leur mise en application 
dans la pratique journalière. Cette mise en application était appuyée par les retours 
d'expérience commentés lors de réunions critiques. Pendant toute cette période de 21 
mois, les praticiens enregistraient des données sur les soins prodigués à leurs patients. 
La concordance entre les directives et les soins réellement dispensés aux cinq groupes 
de malades était exprimée par évaluation de résultats pour chacune des maladies. Une 
évaluation globale était menée parallèlement Accesoirement, on dressa l'inventaire des 
difficultés apparues dans l'application de ces directives. La concordance entre pratique 
et directives ne fut pas totale, mais on constate son amélioration au fil du temps. Cela 
fut particulièrement patent pour le suivi de patients hypertendus et diabétiques en ce 
qui concernait le contenu de chaque visite. Rien ne permettait de dire que la concor-
dance entre directives et pratique réelle était pour ces généralistes le fait d'une 
tendance générale plutôt qu'un fait lié à une maladie précise. Les difficultés menti-
onnées par les médecins comme responsables de défaut de compliance aux directives 
étaient fréquemment d'ordre matériel et liées à des questions d'organisation. Les 
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discussions entre participants à l'enquête ont été fécondes en suggestions. Π apparaît 
que la mise au point et l'utilisation de directives généraient une compliance meilleure 
quand l'impact était immédiat sur le cours de la maladie et sa prise en charge et que 
celle-ci laissait à désirer en cas de retombée indirecte sur le cours des choses. 
Le Chapitre 7 est consacré à l'analyse des résultats obtenus par l'application des 
directives pour l'optimisation du suivi médical. Pendant la durée de cette application, 
les praticiens ne se contentèrent pas de noter quels étaient les'soins réellement 
pratiqués, ainsi qu'il a été dit au chapitre 6, mais ils relevèrent également les pa-
ramètres biologiques recherchés ainsi que la pathologie constatée. Ces différents 
paramètres témoins de l'affection furent définis pour les cinq maladies étudiées. La 
compliance des patients aux visites de suivi, d'une part, et l'observance des directives 
par les praticiens, d'autre part, ont été traitées comme des variables indépendantes. Les 
marqueurs de la pathologie des cinq groupes de patients fluctuèrent tout au long des 21 
mois que dura l'observation, mais sans grand changement On observa une tendance à 
la normalisation des chiffres tensionnels liée à la compliance du patient hypertendu 
ainsi qu'une tendance à la normalisation des taux de glycémie du patient diabétique liée 
aux prestations des médecins. Aucun indice n'a été trouvé en faveur de l'existence d'un 
lien d'ordre général et non lié à l'état pathologique entre la compliance des généralistes 
aux procédures de soins définies dans les directives et des modifications des marqueurs 
des pathologies de leurs patients. On conclut que les paramètres biologiques des 
patients atteints d'ischémie du myocarde (chiffres tensionnels normaux), d'affection 
respiratoire chronique (nombre de poussées) et d'arthrose (nombre d'accès articulaires) 
ne reflètent pas fidèlement leur état pathologique. L'évaluation de la méthode des 
directives thérapeutiques nécessite d'avoir à sa disposition des résultats cliniques et 
biologiques significatifs. 
Le Chapitre 8 est celui des conclusions. On y discute de questions de méthodologie 
et de l'intérêt de ce travail pour des chercheurs et des omnipraticiens. L'étude des 
polypathologies risque d'être biaisée par le facteur âge par exemple. Si l'on peut 
neutraliser méthodologiquement les effets de cette variable, on peut par contre avoir 
des doutes sur la pertinence d'une étude de l'impact net de la polypathologie pour la 
pratique journalière. Π semble que la mise en oeuvre de modèles méthodologiquement 
parfaits se traduise par une diminution de la validité externe des résultats des enquêtes 
sur les soins médicaux prodigués et leurs effets sur les patients. Pour les chercheurs, 
tant épidémiologistes que cliniciens, les problèmes posés par les polypathologies sont un 
vrai défi. Il faudrait arriver à davantage de rigueur dans la définition et l'utilisation de 
la notion de polypathologie en recherche médicale ainsi que dans l'étude des facteurs 
âge, sexe et autres paramètres liés aux patients. L'unique, ou presque unique, source de 
données sur la morbidité et la mortalité en pratique de médecine générale aux Pays-Bas 
mérite donc d'être exploitée davantage. L'élargissement de la recherche sur la qualité 
des soins avec évaluation de la pratique et des résultats est donc indiquée. Il devrait 
être tenu compte de l'état fonctionnel des patients dans cette évaluation. Le rôle des 
médecins généralistes dans le suivi de patients atteints de maladies chroniques se trouve 
confirmé par cette étude. Les malades souffrant de polypathologies relèvent forcément 
de leur compétence. C'est la raison pour laquelle les situations de polypathologies 
devraient être systématiquement incluses dans les 'protocols' de soins optimums à >J 
l'usage des acteurs de la médecine générale aux Pays-Bas. Les programmes visant à 
améliorer la qualité des soins devraient être diversifiés. Le bien-fondé de recherche 
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d'une concordance absolue entre les directives de soins et la pratique courante devrait 
être discuté. La présente étude peut très bien servir de support à des formations en 
matière d'évaluation de résultats pour la médecine générale. 
Zusammenfassung 
Die Studie, die in dieser Dissertation dargestellt wird, ist Teil der Nationalen Nie-
derländischen Untersuchung in Allgemeinpraxen, die das Ziel hat, Einblick in die 
Erkrankungsformen und deren Versorgung durch den Allgemeinarzt zu geben. Dieser 
Teil der Studie befaßt sich schwerpunktmäßig mit chronischen Erkrankungen, insbeson-
dere ihrer Komorbidität und der Qualität der Versorgung. 
Kapitel 1 erläutert den Hintergrund der Hauptthemen dieser Studie und stellt 
Fragen zusammen, die die Studie beantworten möchte. Es liefert auch einige Informati-
onen über die Bedeutung der Allgemeinmedizin in den Niederlanden. Es wird erwartet, 
daß die Prävalenz von chronischen Erkrankungen in der nahen Zukunft aufgrund der 
'Überalterung' der Bevölkerung während der nächsten Jahrzehnte ansteigt. Die 
Hauptaufgabe bei der Betreuung von Patienten mit chronischen Erkrankungen ist es, 
den Zeitraum mit hohem Leidensdruck zu verkürzen. Der Komorbidität bei chroni-
schen Erkrankungen, dem Vorhandensein von mehr als einer chronifizierten Erkran-
kung bei einem Patienten, galt bis vor kurzem wenig Aufmerksamkeit Tatsächlich 
betreut aber der Allgemeinarzt alle Erkrankungen eines Patienten in der täglichen 
Arbeit Für diese Studie sind die folgenden fünf Erkrankungen ausgewählt worden: 
Bluthochdruck, chronische ischämische Herzkrankheit, Diabetes mellitus, chronische 
Erkrankungen der Atemwege und Osteoarthritis in Knie und/oder Hüfte. 
Kapitel 2 faßt die Ergebnisse einer Literaturrecherche zusammen. Ziel der Recher-
che war, Unterschiede in der Definition und dem Umgang mit dem Begriff Komorbi-
dität aufzudecken, um einen Beitrag zur Vereinheitlichung zu leisten. Eine syste-
matische Medline Recherche mit dem Schlagwort 'Komorbidität' lieferte 70 Publikatio-
nen für den Zeitraum zwischen 1985 und 1991. Eine Analyse dieser Publikationen 
machte deutlich, daß Komorbidität in 33 Publikationen ausdrücklich definiert worden 
ist Diese Definitionen reflektierten die Beziehungen zwischen den Einzelerkrankungen: 
die Koexistenz von Erkrankungen, das Vorhandensein von Erkrankungen zusätzlich zu 
einer Index-Erkrankung sowie Nähe und Korrelationen zwischen Erkrankungen. Die 
Erkrankungen, die untersucht worden sind um Komorbidität zu studieren, waren meist 
chronischer Art (Diabetes mellitus, Krebs-, Herzerkrankungen). In den untersuchten 
Publikationen ist Komorbidität am meisten als unabhängige Variable angesehen 
worden. Die Auffaßung von Komorbidität reichte von einer einfachen Darstellung in 
Form von dem Vorhandensein bzw. Nicht-Vorhandensein einer komorbiden Erkran-
kung bis hin zur komplexen Darstellung von Komorbidität als gewichtete Schwere einer 
Erkrankung. Mortalität oder Überleben war die am häufigsten untersuchte Ergebnis-
Variable. Es ist festgestellt worden, daß für ein besseres Verständnis der Bedeutung der 
Komorbidität die Notwendigkeit einer einheitlichen Definition, einer ausdrücklichen 
Darstellung der betrachteten Erkrankung und einer Standardisierung bei den Meß-
größen der Komorbidität besteht 
In Kapitel 3 wird eine Untersuchung der Validität der Diagnosen von chronischen 
Erkrankungen dargestellt. Die Sicherheit mit der eine chronische Erkrankung diagnosti-
ziert wird, ist für den Patienten am wichtigsten, sie ist aber ebenso bedeutsam für 
Morbiditätsstudien. Die Sicherheit einer Diagnosestellung ist operationalisiert worden, 
indem die Übereinstimmung mit den diagnostischen Kriterien analog der Internationa-
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len Klassifikation von Gesundheitsproblemen in der Allgemeinpraxis gemessen worden 
ist Daten über die Durchführung und Resultate von diagnostischen Maßnahmen sind 
retrospektiv durch 15 Allgemeinärzte in sieben Allgemeinpraxen gesammelt worden. 
Die Übereinstimmung mit den diagnostischen Kriterien für die diagnostizierten 
Erkrankungen war hoch, sie reichte von 96% richtig positiven Fällen bei Diabetes 
mellitus bis zu 58% bei chronischen Erkrankungen der Atemwege. Die höchste Rate 
von falsch positiven Fällen war 4%. Die Unterschiede zwischen den 15 Allgemeinärzten 
hinsichtlich der Übereinstimmung bei den Diagnosen ihrer Patienten mit den diagnosti-
schen Kriterien waren auffällig. Es ist die Schlußfolgerung gezogen worden, daß die 
Diagnosen der fünf in Allgemeinpraxen registrierten Erkrankungen im allgemeinen 
valide sind mit einer geringen Anzahl von falsch positiven Fällen. 
Das Ausmaß der Komorbidität der fünf chronischen Erkrankungen hinsichtlich der 
Übereinstimmung mit den diagnostischen Kriterien ist in Kapitel 4 beschrieben. In der 
Bevölkerungsgruppe unter 65 Jahren kommt die Komorbidität nur zu 0.3% vor. 
Personen über 65 Jahren und älter leiden zu 23% an einer oder mehreren der unter-
suchten Erkrankungen. In dieser Patientengruppe leiden 15% an mehr als einer dieser 
Erkrankungen. Patienten mit Osteoarthritis und mit Diabetes mellitus haben die 
höchste Komorbiditätsrate. Komorbidität ist demnach eine klinische Realität der 
Allgemeinpraxis. 
Der Einfluß der Komorbidität von chronischen Erkrankungen auf die Häufigkeit 
der Konsultation eines Allgemeinarztes und auf eine zusätzlich auftretende Erkrankung 
ist in Kapitel 5 beschrieben. Zu diesem Zweck ist die Anzahl der Konsultationen und 
die Inzidenz dazukommender Morbidität für die Dauer von 21 Monaten in fünf 
Kohorten von Patientengruppen entsprechend ihren chronischen Erkrankungen 
untersucht worden. Innerhalb jeder Kohorte ist zwischen Patienten mit einer solchen 
Erkrankung und Patienten mit zwei und mehr der fünf untersuchten Erkrankungen 
unterschieden worden. In jeder Kohorte weisen Patienten mit Komorbidität höhere 
Konsultationsraten auf als Patienten mit einer Erkrankung. Zusätzlich auftauchende Er-
krankungen sind dem Allgemeinarzt häufiger von Patienten mit Komorbidität als von 
Patienten mit einer Erkrankung präsentiert worden. Die häufigsten Erkrankungen, die 
zusätzlich aufgetreten sind, waren akute Erkrankungen wie Myalgien, Infektionen der 
oberen Atemwege und urologische Infektionen. Im Vergleich zur Kontrollgruppe ohne 
chronische Erkrankung, wiesen Patienten mit einer Erkrankung höhere Konsultationsra-
ten, aber kein höhere Inzidenz von zusätzlich auftretende Erkrankungen auf. 
Kapitel 6 beschreibt eine Studie über die Auswirkungen der Erstellung und 
Implementierung von Richtlinien für optimale Nachsorge von Patienten mit chronischen 
Erkrankungen auf die tatsächlich durchgeführte Behandlung. In monatlichen Treffen 
von 15 teilnehmende Allgemeinärzte ist Konsens erreicht worden über Richtlinien, 
gefolgt von ihrer Implementierung in der täglichen Praxis. Die Implementierung ist 
dadurch unterstützt worden, daß in Expertenrunden über die tatsächlich vorgenomme-
nen Maßnahmen Feedback gegeben worden ist Zur selben Zeit haben die Allgemein-
ärzte Daten über die Behandlung gesammelt, die sie innerhalb von 21 Monaten an 
ihren Patienten durchgeführt haben. Die Übereinstimmung zwischen den Richtlinien 
und der tatsächlich durchgeführten Versorgung der 5 verschiedenen Patientengruppen 
wurde mit Hilfe von durchgeführten Maßnahmen pro Erkrankung vorgestellt. Es ist 
über alle Gruppen eine Messung der Maßnahmen ermittelt worden. Zusätzlich ist eine 
Bestandsaufnahme über die Probleme gemacht worden, die während der Implementie-
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rung dieser Richtlinien aufgetreten sind. Die Ausführungen haben keine volle Überein-
stimmung mit den Richtlinien erreicht, aber die Übereinstimmung schien im Laufe der 
Zeit zu wachsen. Dies war besonders auffällig bei der Anwendung der Richtlinien bei 
Patienten mit Bluthochdruck und Diabetes mellitus im Hinblick auf Untersuchungen, 
die bei jedem Praxisbesuch durchgeführt werden müssen. Es gab keinen Anhaltspunkt 
dafür, daß die Übereinstimmung zwischen Richtlinien und tatsächlichen Leistungen ein 
generelles Charakteristikum der Allgemeinarzt noch spezifisch für eine Einzelerkran-
kung ist Probleme, die von den Allgemeinärzte als Begründung für die Diskrepanzen 
zwischen den Richtlinien und den Ausführungen erwähnt werden, betreffen meistens 
organisatorische Gründe. Diskussionen im Expertenkreis führten zu praktikablen 
Vorschlägen. Es wurde diskutiert, daß die Erstellung und Einführung von Richtlinien 
eher zu verbessern ist, wenn die Benutzung dieser Richtlinien einen direkten Einfluß 
auf Verlauf und Behandlung einer Erkrankung hat und schwieriger erscheint, wenn die 
Durchführung den Krankheitsverlauf nur indirekt beeinflußt. 
Kapitel 7 beschreibt eine Untersuchung über die Auswirkungen der Richtlinien auf 
die optimale Nachsorge von Patienten-Ergebnis-Messungen. Während der Implementie-
rung dieser Richtlinien haben die Allgemeinärzte nicht nur Daten über die tatsächlich 
durchgeführte Behandlung gesammelt, wie in Kapitel 6 analysiert, sondern darüber 
hinaus die Ergebnisse der Messungen und der präsentierten Morbidität. Für alle fünf 
chronischen Erkrankungen sind Ergebnis-Messungen definiert worden, die den Zustand 
der Erkrankung beschreiben. Die Compliance der Patienten hinsichtlich der Folgekon-
sultationen und die Ausführungen des Allgemeinarztes analog zu den Richtlinien sind 
als unabhängige Variablen gesetzt worden. Die Indikatoren für den Erkrankungszustand 
der fünf Patientengruppen fluktuierten während des Untersuchungszeitraums von 21 
Monaten, ohne wesentliche Änderungen zu zeigen. Hinweise auf einen Zusammenhang 
zwischen der Patientencompliance und einer Annäherung an einen normotensiven 
Status bei Bluthochdruckpatienten und zwischen den Ausführungen des Allgemeinarztes 
und der Zunahme von normogrycämischem Status bei Diabetiker konnten gefunden 
werden. Es sind keine Hinweise gefunden worden für einen generellen, nicht-krank-
heitsbezogenen Zusammenhang zwischen der Compliance der Allgemeinärzte hinsicht-
lich der Versorgung analog der Richtlinien und Krankheitsveränderungen ihrer 
Patienten. Es ist die Schlußfolgerung gezogen worden, daß die Ergebnis-Messungen für 
Patienten mit chronischen ischämischen Herzerkrankungen (normotensiver Blutdruck), 
chronischen Erkrankungen der Atemwege (Anzahl der Anfälle) und Osteoarthritis 
(Anzahl der Episoden von Gelenkproblemen) den Krankheitszustand nicht gut 
wiedergeben. Die Evaluation der Einführung der Richtlinien verlangt die Verfügbarkeit 
von sinnvollen Maßnahmen- und Ergebnis-Messungen. 
In Kapitel 8 werden Schlußfolgerungen formuliert sowie methodische Ziele und die 
Bedeutung dieser Untersuchung für Forscher und Allgemeinärzte diskutiert. Studien 
über die Auswirkungen der Komorbidität sind in Gefahr den Einfluß von z.B. Alter zu 
betrachten. Dies kann methodisch kontrolliert werden, aber die Relevanz einer 
Untersuchung über die netto Auswirkung von Komorbidität für die täglichen medizini-
sche Praxis kann bezweifelt werden. Es wird suggeriert, daß die Anwendung methodisch 
idealer Modelle die externe Validität von Studienergebnissen, die sich auf Versorgung 
und deren Auswirkungen für den Patienten beziehen, reduziert. Für epidemiologische 
und klinische Forscher stellt das Thema der Komorbidität eine echte Herausforderung 
dar. Es wird vorgeschlagen, eine größere Einheitlichkeit bei der Definition und 
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Handhabung von Komorbidität in der Forschung und in Studien über den Zusammen-
hang mit Alter, Geschlecht und anderen Patientencharakteristika anzustreben. Die 
nahezu einzige Quelle von Morbiditäts- und Mortalitätsdaten in Niederländischen 
Allgemeinpraxen verdient weitere Anwendung. Die Weiterentwicklung der Forschungen 
über die Qualität der Versorgung, mit gleichzeitiger Messung der Maßnahmen und der 
Ergebnisse, ist notwendig. Der funktionale Gesundheitszustand von Patienten sollte bei 
der Messung der Ergebnisse mit einbezogen werden. Für Allgemeinärzte unterstreicht 
die Studie ihre bedeutende Rolle in der Versorgung von Patienten mit chronischen 
Erkrankungen. Patienten mit Komorbidität von chronischen Erkrankungen fordern die 
umfaßende Betreuung durch Allgemeinärtze. Aus diesem Grund sollte Komorbidität 
systematisch in die Niederländischen 'Standards' für eine optimale Versorgung inte-
griert werden. Programme mit der Zielsetzung, die Qualität der Versorgung zu 
verbessern, sollten unterschiedliche Strategien umfassen. Die Relevanz der vollen 
Übereinstimmung zwischen Richtlinien und aktueller Versorgung in der ärztlichen 
Praxis sollte diskutiert werden. Das vorgestellte Modell dieser Studie könnte durchaus 
für Ausbildungsprogramme benutzt werden, die auf die Implementierung einer 
systematischen Evaluation der Effekte von durchgeführter Versorgung in der Allge-
meinpraxis abzielen. 
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Methodological aspects of 70 publications on comorbidity (chapter 2) 
Ref 
# 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
IS. 
16 
17 
18 
Design 
cross-sect 
cross-sect 
cross-sect 
cross-sect 
cross-sect 
cross-sect 
longitudinal 
cross-sect 
cross-sect 
cohort 
cross-sect 
cohort 
Delphi-
process 
cohort 
Place 
comorbidity 
conf/modif 
conf/modif 
outcome var 
outcome var 
conf/modif 
outcome var 
outcome var 
conf/modif 
indep var 
indep var 
outcome var 
indep var 
indep var 
outcome var 
Measure * 
N of dis 
comY/N 
N of dis 
spec dis Y/N 
spec dis Y/N 
com Y/N 
spec dis Y/N 
com Y/N 
N of dis 
N of dis 
com Y/N 
spec dis Y/N 
spec dis Y/N 
index 
spec dis Y/N 
Index disease/ 
condition 
arthritis 
arthritis 
-" 
diabetes mellitus 
arthritis 
epilepsy 
cancer on death 
certificate 
arthritis 
arthritis 
chronic pain 
multiple sclerosis 
rheumatoid 
arthritis 
gastrointestinal 
diseases 
recurrent 
spontaneous 
abortion 
Main outcome 
variable(s) 
disability 
earnings 
losses 
comorbidity 
comorbidity 
a. disability 
b. earnings loss 
comorbidity 
trends in 
cause of death 
disability 
disability 
response to epidural 
electrical stimulation 
comorbidity 
mortality 
appropriateness 
of procedures 
comorbidity 
N of dis: number (sum) of diseases; com Y/N: comorbity present or absent (one variable); 
spec dis Y/N: specific diseases separately present or absent (multiple variables). 
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Ref Design Place Measure Index disease/ Main outcome 
# comorbidity condition variables) 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
cross-sect 
cohort 
case-control 
case-control 
cohort 
validation 
study 
cohort 
cohort 
cohort 
cohort 
validation 
study 
validation 
study 
cohort 
indep var 
outcome var 
outcome var 
outcome var 
conf/modif 
indep var 
Cgolden 
standard') 
indep var 
conf/modif 
conf/modif 
conf/modif 
variable to 
be validated 
one of the 
variables to 
be validated 
indep var 
N of dis 
comY/N 
spec dis Y/N 
spec dis Y/N 
spec dis Y/N 
index 
index 
com Y/N 
N of dis 
spec dis Y/N 
index 
index 
com Y/N 
com Y/N 
rheumatoid 
arthritis 
chronic urticaria 
lichen planus 
essential tremor 
migraine headache 
cognitive 
impairment 
hospital admission 
hospital admission 
stroke 
diabetic 
hyperosmolar 
state 
breast cancer 
hospital admission 
hospital admission 
cancer 
a. correlation with 
index disease 
and depression 
b. functional status 
and demand for 
care 
comorbidity 
comorbidity 
comorbidity 
in-hospital 
morbidity 
and mortality 
accuracy of 
estimation 
of illness 
severity 
a. preference 
for intervention 
type 
b. in-hospital 
course 
disability and use of 
services 
mortality 
pattern of care 
accuracy of 
prediction 
of mortality 
use of health care 
after hospital 
admission 
complications and 
mortality 
Reí Desiga Place Measure * Index disease/ Main outcome 
# comorbidity condition variable(s) 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
cross-sect 
cohort 
validation 
study 
cohort 
cohort 
validation 
study 
cohort 
longitudinal 
validation 
study 
cohort 
cohort 
case-control 
cohort 
case-control 
cohort 
conf/modif 
indep var 
one of the 
variables to 
be validated 
indep var 
indep var 
one of the 
variables to 
be validated 
indep var 
outcome var 
one of the 
variables to 
be validated 
indep var 
indep var 
indep var 
a. indep var 
b. conf/modif 
indep var 
indep var 
index 
N of dis 
N of prescriptions 
index 
index 
N of dis 
index 
spec dis Y/N 
spec dis Y/N 
com Y/N 
spec dis Y/N 
spec dis Y/N 
N of dis 
spec dis Y/N 
spec dis Y/N 
spec dis Y/N 
com Y/N 
cancer 
myocardial 
infarction 
cataract 
hospital admission 
lupus nephritis 
prostatectomy 
cholecystectomy 
bypass surgery 
cardiac surgery 
cardiac 
reoperation 
blood culture 
hypertension 
diabetes mellitus 
anaesthesia 
trauma 
coronary heart 
disease 
sternotomy 
non-Hodgkin 
lymphoma 
hospital 
mortality rates 
outcome at 
discharge 
visual acuity 
one-year survival 
renal failure and 
mortality 
readmission 
and mortality 
mortality 
trends in patient 
characteristics 
and mortality rates 
result of blood 
culture 
intraoperative 
hypotension or 
hypertension 
mortality 
mortality 
a. disability 
b. differences 
between sexes 
infection and 
mortality 
morbidity and 
mortality 
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Ref Design Place Measure Index disease/ Main outcome 
# comorbidity condition variable(s) 
47 cohort indep var spec dis Y/N cecal pseudo­
obstruction 
treatment type 
48 reliability comparison spec dis Y/N prostatectomy 
study variable cholecystectomy 
agreement 
between two 
data sources 
49 
50 
51 
cohort indep var spec db Y/N 
cohort indep var spec dis Y/N 
cohort conf/modif index 
lower limb 
amputation 
benign prostatic 
hyperplasia 
bypass surgery 
walking ability 
perioperative 
complications 
hospital and 
surgeon mortality 
rates 
52 validation. one of the N of dis 
study variables to 
be validated 
hospital admission hospital 
mortality rates 
53 cohort a. indep var index 
b. conf/modif 
acute myocardial a. hospital means 
infarction, bypass of length of stay 
surgery, total hip b. mortality, 
54 
55 
56-64 
65 
66 
67 
68 
review 
cohort 
not included 
cross-sect 
cross-sect 
cohort 
cohort 
conf/modif 
indep var 
in review 
outcome var 
indep var 
indep var 
conf/modif 
spec dis Y/N 
spec dis Y/N 
spec dis Y/N 
N of dis 
spec dis Y/N 
N of dis 
N of dis 
replacement, < 
cystectomy 
scleroderma 
rheumatoid 
arthritis 
hypertension 
-
rheumatoid 
arthritis 
chole- functional status, 
readmission, 
patient statis-
faction 
mortality 
length of stay 
comorbidity 
disability 
a. mortality 
b. incident 
morbidity 
с occunence 
of depression 
health 
outcome 
Ref Design Place Measure * Index disease/ Main outcome 
# comorbidity condition variable(s) 
69 
70 
71 
72 
73 
74 
75 
76 
77 
78 
79 
80 
81 
cross-sect conf/modif spec dis Y/N 
cross-sect comVmodif N of dis 
longitudinal conf/modif spec dis Y/N 
cross-sect conf/modif N of dis 
cross-sect conf/modif index 
cross-sect conf/modif com Y/N 
cohort 
cohort 
conf/modif index 
cohort indep var a. spec dis Y/N 
b. com Y/N 
cross-sect conf/modif N of dis 
conf/modif com Y/N 
cohort outcome var spec dis Y/N 
validation variable to spec dis Y/N 
study be validated 
cross-sect indep var N of dis 
cohort indep var spec dis Y/N 
cohort indep var spec dis Y/N 
arthritis 
rheumatoid 
arthritis 
wage earnings 
treatment 
acute myocardial case fatality 
infarction rate and survival 
bypass surgery, mortality for ranges 
aneurysm resect- of hospital and 
ion, gastrectomy, surgeon volume 
colectomy, chole-
cystectomy 
17 conditions 
16 conditions 
mortality 
length of stay and 
mortality 
intensive care 
admission 
endometrial 
cancer 
cerebrovascular 
accident, myo-
cardial infarction, 
pneumonia 
benign prostatic 
hypertrophy 
mortality 
survival 
hospital mortality 
rates 
mortality rates, 
reoperation rates 
admission geriatric comorbidity 
unit 
diabetes mellitus accuracy of prediction 
of death and occurr-
ence of complications 
disability 
a. decline of 
functioning 
b. mortality 
admission long term 
and/or mortality 
109 
Ref Design Place Measure * Index disease/ Main outcome 
# comorbidity condition variablees) 
82 cohort indep var spec dis Y/N - longevity 
83 cohort outcome 'var spec dis Y/N diabetes mellitus comorbidity 


Stellingen 
1. De huisarts is de 'controlerend geneesheer' bij uitstek voor patiënten met comorbi-
diteit van chronische ziekten. 
2. Epidemiologisch onderzoek naar comorbiditeit vereist het analyseren van ziekten op 
patiëntniveau. 
3. In NHG-standaarden dient bij chronische ziekten standaard aandacht besteed te 
worden aan comorbiditeit 
4. Iemand met een chronische ziekte is lang niet altijd chronisch ziek. 
5. Les patients patients n'ont que rarement besoin d'un médecin. 
6. Artsen onderschatten zelfzorg. 
7. Helpen is niet hetzelfde als aan de hulpvraag beantwoorden. 
8. Geneeskunst vereist kunde. 
9. Het routinematig vaccineren van jongens tegen rubella is overbodig medisch 
handelen. 
10. Specialisten zijn er dankzij het bestaan van generalisten en niet andersom. 
11. Begeleiding van een onderzoeker betekent ook scholing van de begeleider. 
12. De vermelding 'Deze ruimte alleen gebruiken voor doeleinden waarvoor deze is 
bestemd Art 7 AVR' op een bord in ruimtes op NS-stations schept geen duidelijk-
heid over de bestemming en is derhalve zinloos. 
13. Het hanteren van een uniforme pensioengerechtigde leeftijd is een miskenning van 
de individuele mogelijkheden en talenten van ouderen. 
14. Doctores zijn ook mensen. 
15. ...'De dominee, de dokter, de notaris, 
Drievuldig beeld van al wat wijs en waar is. 
Maar 't kan verkeren'... (J. Greshoff) 
Stellingen behorend bij bet proefschrift van François Schellevis: Chronic diseases in general practice. 
Nijmegen: Katholieke Universiteit, 30 november 1993. 



